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ABSTRACT OF THE DISSERTATION 
The Role of MDA5 and TLR3 in Response to dsRNA and Viral Infection 
By 
Stephen Andrew McCartney 
Doctor of Philosophy in Biology and Biomedical Sciences 
(Immunology) 
Washington University in St. Louis, 2010 
Professor Marco Colonna, Chairperson 
 
 The innate immune system consists of a number of genetically encoded receptors 
that detect the products of viral replication and initiate signaling cascades leading to 
activation of the antiviral response.  During the course of infection, many viruses produce 
dsRNA that can be recognized by two major arms of the innate immune system: the toll-
like receptors (TLR) and the Rig-I-like receptors (RLR).  Among the TLRs, TLR3 binds 
dsRNA within the endosomal compartment and initiates signaling through its 
downstream adapter TRIF.  Melanoma differentiation-induced gene 5 (MDA5) is a 
member of the RLR family that recognizes dsRNA within the cytosolic compartment and 
signals through the adaptor IPS-1.  Although TLR3 and MDA5 initially employ distinct 
downstream adaptors, both are known to induce the production of cytokines and cell 
surface molecules involved in the antiviral response, which raises the question of whether 
they are redundant or functionally distinct.  Using mice that are genetically deficient for 
MDA5, TLR3, or both MDA5 and TLR3 (double knockout, DKO), we have 
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demonstrated that these receptors have unique functions necessary for controlling viral 
infection.   
 Using two models of viral infection, murine norovirus (MNV) and 
encephalomyocarditis virus (EMCV), we demonstrate that both MDA5 and TLR3 limit 
viral replication.  Neither MDA5-/- nor TLR3-/- animals controlled MNV and EMCV 
infection as well as wild type (WT) controls, but DKO mice were more susceptible to 
infection than either single knockout.  Furthermore, we find that MDA5 and TLR3 play 
distinct roles in activating the natural killer (NK) cell response to the dsRNA analogue 
poly I:C (pIC).  We demonstrate that the discrete functions of MDA5 and TLR3 are 
dependent on their expression in different cell types as well as their unique capacities to 
control production of cytokines.  In addition, we show that the individual contribution of 
each sensor is necessary at distinct phases of the innate immune response, with TLR3 
acting initially and MDA5 acting at later time points.  These results illustrate how 
cooperation between the TLR and RLR pathways is necessary for the development of a 
complete antiviral response. 
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Abstract 
 Viral pathogens have been discovered in all species from single-cell bacteria to 
the largest mammals.  In order to protect themselves from the pathogenic effects of these 
invaders, organisms have been required to develop mechanisms to detect and limit viral 
infection.  In mammals this requirement has evolved the adaptive immune system, which 
is able to generate highly specific antibodies and T cells that recognize specific viral 
proteins and peptides that either block infection or target infected cells for destruction.  
Initiation of the adaptive immune response, however, is a slow process that requires days 
to weeks for maximum effect.  To provide protection during the initial hours and days of 
infection mammals have maintained a system of pattern-recognition receptors (PRR) first 
seen in lower organisms that recognize broad motifs common to viral pathogens and thus 
serve as the initial sensors of viral infection.  These sensors initiate the adaptive antiviral 
response as well as trigger the innate immune pathways that protect the host during early 
infection while the more specific adaptive response develops.  This chapter will provide 
an introduction to the role of small non-enveloped RNA viruses in human disease, 
describe the innate immune response to infection with these viruses, and detail the 
molecular pathways responsible for the detection of viral infection. 
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Small RNA viruses in disease 
 Members of the picornaviruses and caliciviruses families consist of small, non-
enveloped viruses containing a positive-sense RNA genome1.  Although small, viruses 
from these families are responsible for a surprisingly large number and range of human 
diseases as shown in Table 1.1.  These viruses are typically transmitted in a fecal-oral 
manner and replicate in the alimentary tract, although several can also be spread through 
respiratory transmission.  Several picornavirus family members can also cause systemic 
as well as gastrointestinal illness in humans and animals, such as encephalitits, 
myocarditis, hepatitis, and have been linked to type 1 diabetes1.  Caliciviruses have been 
shown to be the most common cause of nonbacterial epidemic gastroenteritis worldwide2-
6 and have mostly been detected in the gastrointestinal tract. 
 Picornavirus and calicivirus genomes both contain a unique 5’ covalent linkage to 
a protein called VPg, which has been linked to a role in viral RNA synthesis 7-9.  
Picornaviruses contain a single long open reading frame (ORF) and viral proteins are 
obtained from processing of the polyprotein1.  Caliciviruses have at least two ORFs and 
the exact number depends on the genus10,11.  Picornaviruses gain entry to cells by 
attaching to host cell membrane receptors.  A variety of receptors are employed by 
different viruses, including CD155 (poliovirus), VCAM-1 (EMCV), DAF (coxsackie A 
viruses), and Coxsackievirus-Adenovirus Receptor (coxsackie B viruses)1.  The cellular 
receptors for caliciviruses are currently unknown, but human volunteer studies suggest 
that replication occurs in the upper intestinal tract 12,13.  The use of different receptors for 
entry by picornavirus and calicivirus family members likely results in the distinct viral 
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tropism and ability to cause different diseases, some of which will be discussed in more 
detail below. 
 
Myocarditits 
 Myocarditis is a cardiac disease in which the myocardium becomes inflamed and 
injured in the absence of an ischemic event.  Most cases of myocarditis have been linked 
to an infectious origin, with viruses being the most common cause in North America14.   
At least 20 viruses have been linked to the disease15, but in humans, coxsackie viruses 
seem to be the dominant pathogen16,17.  The incidence of myocarditis is unclear because 
most cases are likely to be asymptomatic and even in cases in which endometrial biopsy 
is available there is disagreement among pathologists about the exact diagnostic criteria18.  
However, most studies have shown that a majority of cases occur in children and young 
adults.  The disease consists of three phases: acute, subacute, and chronic.  In the acute 
phase there is active viral replication in the myocardium, the initial production of 
inflammatory cytokines, and a limited macrophage and NK cell infiltrate.  The subacute 
phase consists of viral release, a large lymphocytic infiltrate, and a more massive 
cytokine response leading to viral clearance.  The chronic phase typically consists of very 
low levels or the absence of viral particles but also fibrosis and remodeling of the 
myocardium leading to dilated cardiomyopathy and congestive heart failure14. 
 The availability of several mouse models of myocarditis has begun to reveal some 
of the mechanisms of disease progression.  A.BY/SnJ and SWR/J strains of mice have 
been shown to be susceptible to a more chronic form of myocarditis while C57BL/6 and 
DBA1/J strains have a more acute, rapidly clearing form of the disease when infected 
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with either coxsackie B virus (CVB) or EMCV19-21.  Using these models, there are 
currently three main theories concerning the mechanism of myocardial damage that 
occurs in viral myocarditis14.  1. Excessive immune-mediated destruction of virally 
infected and surrounding myocardium by immune infiltrates.  2. Autoimmune destruction 
of myocardium by self-reactive cells and antibodies triggered by release of cardiac 
proteins or viral mimicry. 3. Direct myocardial injury by virus.  There is evidence of all 
three forms of myocardial damage in different models22-24.  Based on these somewhat 
contradictory results, it is currently unclear whether the immune system is protective or 
pathogenic in viral myocarditis.  Recent experiments have demonstrated that anti-
inflammatory cytokine IL-10 and in a human clinical trial, anti-viral cytokine IFNβ have 
protective effects in myocarditis and result in improved cardiac function25,26.  However, 
in other clinical trials, general immunosuppression with prednisone had no significant 
effect on the outcome of myocarditis27.  These studies highlight the complexity of the 
balance between the protective and harmful effects of the immune response to 
myocarditis and the potential that myocarditis is not one disease but rather a collection of 
diseases with differing etiologies. 
 
Diabetes 
 Type 1 diabetes mellitus (T1DM) is caused by progressive destruction of the beta 
(β) cells in the pancreatic islets leading to hypoinsulinemia and hyperglycemia.  
Population based and familial studies as well as animal models have revealed that several 
genetic factors contribute to the risk of developing the disease, however, the precise 
mechanisms that lead to the initiation and development of T1DM remain unknown 28,29.  
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The high discordance rate (<50%) of T1DM in monozygotic twins as well the rapidly 
increasing incidence rates in certain geographic locations strongly suggest that 
environmental factors also contribute to the disease30,31.  It has long been hypothesized 
that viral infection may be related to T1DM32.  Indeed, human studies have found virus-
specific antibodies in the serum and viral antigen in the pancreatic islets of recent onset 
T1DM patients33-35.  There are several theories explaining how viral infection could lead 
to T1DM including: (i) direct virus-mediated destruction of β-cells, (ii) molecular 
mimicry of host proteins by viral antigens36, (iii) release of novel antigens from β-cells 
upon viral infection leading to activation of auto-reactive cells37, (iv) the production of 
inflammatory and immune cytokines that cause bystander activation38, and (v) production 
of type I interferon (IFN) by infected cells leading to increased immune targeting of β-
cells39. Although a number of different viruses have been linked to T1DM, the most 
common association in humans is with coxsackieviruses40-42.   
  A variety of animal models have also provided evidence that viruses can trigger 
T1DM.  Infection of the Biobreeding (DR-BB) rat with Kilham rat virus and susceptible 
mouse strains with encephalomyocarditis virus (EMCV) lead to diabetes in those 
normally resistant animals43,44.  In addition, T1DM was induced in mice after infection 
with a CVB4 strain isolated from a human patient with diabetic ketoacidosis40.  
Conversely, there is also evidence that viruses can be protective and limit development of 
T1DM in susceptible individuals.  Indeed, this is proposed in the hygiene hypothesis45, 
originally proposed for asthma, which attempts to explain the increasing incidence of 
autoimmune diseases as a result of lower incidence of enterovirus infection.  In support 
of this theory, NOD mice, which develop an autoimmune T cell mediated T1DM similar 
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to human disease, are protected from diabetes development if infected with EMCV of 
CVB before the initiation of disease46.  Further studies have suggested that viruses which 
replicate quickly cause T1DM, while slowly replicating viruses are protective for the 
disease47.  One potential explanation for this apparent paradox has been suggested by 
histological studies from human pancreatic tissues.  Studies from Dotta at al have shown 
two distinct patterns of T1DM in human pancreatic islets35.  Pattern A is the classic 
autoimmune form consisting of a T cell infiltrate similar to the disease seen in the NOD 
mouse.  Pattern B samples do not have T cell infiltrates, instead displaying marked 
increases in natural killer (NK) cells and macrophages within the islets.  Pattern B 
samples are also more likely to include viral antigen than pattern A.  This suggests that 
T1DM may consist of multiple disease processes in which virus play distinct, even 
contradictory roles.  
 
Gastroenteritis 
 In humans, viral gastroenteritis results in vomiting, diarrhea, fever, malaise, and 
abdominal pain within 24-48 hours after infection.  These symptoms usually clear within 
48-72 hours, but virus can persist for 3-6 weeks post-infection48,49.  Viral gastroenteritis 
can occur in clusters in a variety of settings such as hospitals, nursing homes, day care 
centers, and cruise ships.  Advances in diagnostic techniques has revealed that 90% of 
viral gastroenteritic outbreaks and up to 36% of sporadic gastroenteritis cases can be 
attributed to Norwalk virus and other human noroviruses2-6.  There is great genetic 
diversity among both human and animal noroviruses.  A recent comparison of norovirus 
sequences from around the world has suggested that a new pandemic strain emerges 
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every 2-4 years, indicating the importance of understanding the pathogenesis of 
infection50. 
 Until recently the inability to culture norovirus in vitro as well as the lack of an 
animal model have limited investigation into its pathogenicity.  The discovery and 
subsequent culture of murine norovirus-1 (MNV-1) has thus led to advances in 
understanding both the viral lifecycle as well as the host response to infection51,52.  These 
studies have demonstrated that mice defective in the innate immune response  are more 
susceptible to severe norovirus infection.  Similarly, human studies have revealed 
increased susceptibility to norovirus infection in the very young, elderly, and 
immunocompromised individuals50.  Recent reports have also suggested additional 
disease susceptibility factors.  Noroviruses have been shown to bind to histo-blood group 
antigens of the ABO, Lewis, and secretor families, and strain-specific susceptibility to 
infection is dependent on blood group antigen and secretor status53-56.  However, the wide 
diversity of norovirus strains suggests that individuals who are resistant to one strain, 
may be susceptible to another.  
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Innate Immune response to small RNA virus infection 
 During viral infection a variety of cellular responders are activated to contain and 
clear the infection.  Upon penetration of the epithelial barriers and infection within host 
tissues viruses, their replication products, and infected cells are recognized by tissue 
phagocytic cells such as macrophages, neutrophils and dendritic cells, which produce 
inflammatory and antiviral cytokines that serve to activate the innate immune response.  
These cytokines, which will be detailed in the following sections, activate NK cells and 
other innate lymphocytes, induce phagocyte maturation, lead to production of acute phase 
antiviral products from the liver, and upregulate cell intrinsic antiviral responses.  All of 
these effects constitute the innate antiviral response. 
 
Cellular 
NK cells 
 NK cells develop from the common lymphocyte progenitor, but unlike 
lymphocytes of the adaptive immune system, do not undergo genetic recombination of 
their antigen receptors genes.  Instead NK cells employ a variety of invariant receptors 
that recognize cell surface receptors that are differentially modulated on virally infected 
cells57.  NK cells express both activating and inhibitory receptors on their cell surface and 
the two-receptor hypothesis describes how these opposing receptors control their 
activation58.  Activating receptors bind ligands that are induced upon cellular stress such 
as viral infection or transformation and signal for NK cytotoxicity against cells 
expressing the target ligand.  Inhibitory receptors bind MHC class I molecules which 
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traditionally present peptides to CD8 T cells of the adaptive immune system and are 
normally expressed on healthy cells. The presence of inhibitory receptors prevents NK 
cytotoxicity against uninfected targets.  However, during infection, many viruses 
downregulate MHC class I surface expression in order to evade the adaptive immune 
response.  If this occurs, then NK cell inhibitory receptors do not engage their ligand 
resulting in an activating response and cytotoxicity.  In addition to their cell surface 
receptors, NK cells are activated by type I IFN and inflammatory cytokines produced 
during viral infection, which result in increased baseline NK cell activation and cytotoxic 
ability59.  NK cells have been demonstrated to be important for control of both CVB and 
EMCV infection in the context of myocarditis and diabetes60,61. 
Innate-like lymphocytes 
 Innate-like lymphocytes (ILL) are cells of the lymphocyte lineage, which, similar 
to NK cells, function in the innate immune system.  There are two main types of ILLs 
involved in control of viral infection, intraepitheial γ:δ T cells and NK T cells.  Among 
γ:δ T cells, there are two subsets, one which rearranges antigen receptor genes similar to 
α:β T cells known as lymphoid γ:δ T cells, and intraepithelial γ:δ T cells.  Unlike other T 
cell types, intraepithelial γ:δ T cells have antigen receptors of very limited diversity62.  
These cells are typically located in the skin and mucosal surfaces and are thought to 
recognize a poorly defined selection of pathogen and host derived ligands directly, 
independent of presentation on MHC molecules63.  NK T cells express an invariant T cell 
antigen receptor α chain and a limited selection of T cell β chains64.  With this unique 
antigen receptor, NK T cells have been demonstrated to recognize lipid antigens 
presented on CD1d molecules.  These cells are located within lymphatic tissues and are 
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thought to play a role in rapid secretion of cytokines early during infection.  
Intraepithelial γ:δ T cells have been demonstrated to play a role in CVB myocarditis65, 
while NK T cells have been implicated in EMCV-induced diabetes in animal models66. 
Phagocytes 
 Macrophages, dendritic cells, and neutrophils have all been implicated in the 
innate response to picornavirus infection67-70.  These cells are known to phagocytose 
infected cells as well as function in the production of antiviral and inflammatory 
cytokines.  Phagocytosis of virally infected cells serves two functions.  First, 
phagocytosis by macrophages and neutrophils results in degradation of viral particles by 
lysosomal enzymes as well as reactive oxygen and nitrogen species leading to clearance 
of infectious particles and control of infection.  Second, phagocytosis and degradation 
allows for recognition of viral products by PRR within macrophages and neutrophils.  
These receptors, which will be described in detail in later sections, stimulate the 
activation of phagocytic cells leading to increased antigen presentation, cytokine 
production, and inflammatory mediators.  Unlike macrophages and neutrophils, which 
function at the site of infection, dendritic cells (DC) gather antigen from the site of 
infection, then migrate to lymphatic tissues, where they function in the initiation of the 
adaptive immune response.  As part of this response, they produce large amounts of 
cytokines, which besides informing the adaptive response, contribute to activation of the 
innate response.  In particular, DCs have been implicated in activation of the NK cell 
response to viral infection71.     
 
Cytokines 
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 Viral infection induces the production of a variety of antiviral and inflammatory 
cytokines from both infiltrating immune cells as well as infected cells themselves. Type I 
IFN is acknowledged as a critical mediator of the antiviral response necessary to limit 
viral infection, but inflammatory cytokines also recruit immune cells necessary for 
control of infection. 
Interferons 
 The initiation of IFN production is an essential step in the antiviral response.  
There are three type of IFN produced during infection.  Type I IFNs (IFN-α, IFN-β, IFN-
ω, IFN-ε, and IFN-κ ) fight viruses both directly by inhibiting viral replication in cells 
and indirectly by stimulating the innate and adaptive immune responses72. Type II IFN, 
also known as IFNγ, has distinct functions compared to type I and type III IFNs.  This 
cytokine is produced by activated T cells, NK cells, and NK T cells and acts primarily on 
macrophages leading to their activation and increased ability to kill intracellular 
pathogens as well as stimulation of the adaptive immune response73.  It has a much more 
limited role on virally infected cells themselves.  Recent studies have led to the 
identification of type III IFNs (IFN-λ). These include three proteins, named IFN-l1, IFN-
l2, and IFN-l3, or interleukin-29 (IL-29) (l1) and IL-28A/B (l2/3).  Although genetically 
distinct from type I IFNs, type III IFNs have similar biological antiviral functions 74-76.   
In contrast to type II IFN, type I and type III IFN can be produced by almost all nucleated 
cells allowing for a variety of cells to initiate an antiviral response.  A major difference 
between type I and type III IFN, however, is that while the type I IFN receptor is 
ubiquitously expressed, the type III IFN receptor has a more limited distribution, 
suggesting some cellular specificity in the IFN response77,78. 
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 IFN-α and IFN-β bind to the IFNα receptor (IFNAR) in an autocrine or paracrine 
manner.  Activation of this receptor leads to JAK/STAT signal transduction pathways 
79,80 and the induction of a variety of IFN-induced genes.  These genes increase the 
cellular resistance to viral infection and sensitize virus-infected cells to apoptosis 81.  
Interestingly, several viral sensors, which will be discussed in more detail later, are 
among those genes induced by IFN.  They in turn enable the production of IFN, creating 
a positive feedback loop that enhances the response. In addition type I IFNs directly 
activate DC and NK cells, and promote the survival and effector functions of T and B 
cells, providing a link between the innate response to infection and the adaptive immune 
response 82-85.  The importance of type I IFN in control of viral infection is evidenced by 
several mutations in mice and humans that affect this pathway and lead to severe 
sensitivity to viral infection86-88, as well as the number of viruses that encode inhibitors of 
IFN pathway components89.   
 Although type I IFN is critical for the control of virus infection, it has also been 
linked to a variety of autoimmune diseases such as systemic lupus erythematosus, 
rheumatoid arthritis, Sjögren’s syndrome, systemic sclerosis, and myositis72.  
Autoimmune phenomena has also been seen in patients treated with IFN in the context of 
viral infection90.  It has recently been suggested that IFN is an initiating event in T1DM.  
This is suggested by reports that IFN-induced gene upregulation is seen in islet samples 
from newly diabetic patients35,91.  In this context, IFN could function to upregulate 
antigen presentation of β-cell antigens as well as activate immune cells leading to 
autoimmune destruction of islets92 or perhaps lead to direct cytotoxic effects93.  
Paradoxically, stimulation with IFN-inducing agents, such as dsRNA or virus, have a 
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protective effect in the NOD mouse and BB rat models of T1D46,94.  Additionally, 
production of IFNα and IFNβ was shown to be critical for prevention of CVB-induced 
diabetes in a mouse model95.  In this system IFN reduced the permissiveness of β-cells to 
infection and limited NK-mediated death of these cells.  These disparate results illustrate 
that although IFN is necessary for control of viral infection, disregulation or 
overproduction may also induce autoimmune pathology. 
Inflammatory cytokines 
 In addition to IFN signaling, inflammatory cytokine and chemokines also play a 
role in control of viral replication.  Both dendritic cells (DC) and macrophages produce 
TNFα, IL-6, MCP-1, and IL-12 in response to viral infection.  In addition these same 
inflammatory cytokines are often detected in the serum of virally infected animals.  
Inflammatory cytokines activate the vascular endothelium as well as stimulate the 
recruitment of immune cells such as monocytes and neutrophils.  IL-6 has been shown to 
be important to limit damage during CVB infection96, while TNFα has been shown to 
lead to enhanced pathogenicity with the same virus97.  These results demonstrate that 
although the inflammatory response is important in the clearance of viral infection, a 
prolonged inflammatory state can also lead to adverse reactions including necrosis of 
local tissue and autoimmune diseases, so careful regulation is critical. 
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Sensors involved in detection of viral products 
 The innate immune response provides protection during the early stages of viral 
infection.  However, activation of both the cellular and cytokine responses requires the 
host to recognize an ongoing infection.  To accomplish this, organisms take advantage of 
pathogen associated molecular patterns (PAMP), which are specific for microbial 
components typically seen in the context of infection.  These PAMPs are recognized by 
pattern recognition receptors (PRR) of the innate immune system that rapidly signal for 
the initiation of the antiviral response.  Two distinct groups of PRRs include the Rig-I 
like receptors (RLR) and the Toll-like receptors (TLR).  These two pathways, along with 
other components, provide a means for cells to detect the presence of viral pathogens. 
 
Rig-I like receptors 
 RLRs are cytoplasmic proteins that recognize viral products that have gained 
access to the cytosol.  There are currently three known members of this family: retinoic 
acid-inducible gene I (Rig-I), melanoma differentiation-associated gene 5 (MDA5), and 
laboratory of genetics and physiology-2 (Lgp2)98.  Rig-I and MDA5 both contain a 
DExD/H box helicase domain that binds double stranded RNA (dsRNA) and two N-
terminal caspase recruitment (CARD) domains involved in signaling 99-102.  Lgp2 
contains the helicase domain, but lacks the CARD domains, and was originally thought to 
be a negative regulator 103,104.  However, recent reports indicate that it may have an 
activating function in response to certain viruses105,106.  Both Rig-I and Lgp2 also contain 
a C-terminal repressor domain that blocks signaling in the absence of ligand binding 102. 
Rig-I binds preferentially to ssRNAs that are phosphorylated at the 5’ end 107,108 and 
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contain homopolyuridine or homopolyriboadenine motifs as well as short dsRNA 109-111.  
MDA5 recognizes long dsRNAs and does not require 5’ phosphorylation 110-113.  
Crystallization studies have determined that the differential ligand binding capacities of 
Rig-I and MDA5 are dependent on structural differences in the C-terminal domain of the 
protein114,115.  The different ligand preferences of the two proteins is thought to result in 
specificity for the recognition of individual viruses.  
 Both MDA5 and Rig-I signal through CARD-CARD interactions with IPS-1 (also 
known as MAVS, VISA, or Cardiff), which is located on the outer mitochondrial 
associated membrane 116-119.  Downstream of IPS-1 120, TRAF3 activates TBK1 and 
IKKe, which phosphorylate IFN regulatory factor 3 (IRF-3) and IRF-7 121,122.  Activated 
IRF-3 and IRF-7 translocate into the nucleus and bind IFN stimulated response elements 
(ISREs), inducing the expression of type I IFNs 123.  IPS-1 also interacts with FAS-
associated death domain-containing protein (FADD) 124.  FADD activates caspases-8 and 
-10, and the activation of the caspase death effector domains activates NF-kB, leading to 
the production of inflammatory cytokines 125.  A schematic of RLR signaling is shown in 
Figure 1.1.   
 
Toll like receptors 
 TLRs are transmembrane proteins that contain luminal leucine-rich repeats 
(LRRs) that sense pathogen associated molecular patterns and cytoplasmic Toll/IL-1 
receptor homology (TIR) domains that signal through downstream adaptors 98. There are 
10 members of the TLR family in humans and 13 in mice.  TLRs involved in the 
detection of viral nucleic acids are located on the cell surface (TLR3) or in endosomal 
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compartments (TLR3, 7, 8, and 9) 126.  TLR3 recognizes dsRNA, which constitutes the 
genome of dsRNA viruses and is also an intermediate produced during replication of 
single stranded (ss) RNA viruses 127.  TLR7 and 8 recognize ssRNA as well as 
imidazolequinilone compounds, which are known to have antiviral properties 126,128-131.  
TLR9 recognizes unmethylated CpG-containing DNA, which is commonly found in the 
genomes of DNA viruses132,133.  
 TLR3 signals through the adaptor protein TRIF 134,135.  TRIF interacts with 
TRAF3 and TRAF6 through TRAF-binding motifs and with RIP1 and RIP3 through 
RHIM motifs 136-138.  TRAF3 leads to the secretion of type I IFNs, while TRAF6 and 
RIP1 lead to NF-kB activation and production of inflammatory cytokines 139. TLR7, 8, 
and 9 signal through the adaptor protein myeloid differentiation primary-response gene 
88 (MyD88).  MyD88 contains a TIR domain as well as a death domain that allows it to 
serve as an adaptor for TLR signaling.  MyD88 associates with a signaling complex 
consisting of TRAF6, BTK, IRAK4, and IRAK1 140.  Signaling through this complex 
activates IRF7, NF-kB, and MAP kinase pathways 141-143.  Thus, although RLRs and 
TLRs signal through different pathways, both appear to be able to activate the production 
of type I IFNs (i. e. IFN-a and IFN-b) and inflammatory cytokines. 
 Two additional TLR family members that signal through MyD88 have been 
implicated in the recognition of non-nucleic acid viral components. TLR2 is known to 
detect a variety of lipoproteins as well as yeast-associated zymosan, however, it has also 
been demonstrated to have a role in the recognition of viral envelope proteins 144.  A 
recent study has also described a role for TLR2 in detection and the early IFN response to 
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poxvirus infection145.  Similarly, while TLR4 has traditionally been known as the sensor 
of LPS, it can also respond to viral-derived envelope glycoproteins 146.  
 
1.9 Additional sensors (non-TLR, RLR) 
 The TLRs and RLRs have been shown to play a role primarily in RNA virus 
infection.  Recently, the array of innate immune sensors of viral infection has been shown 
to include additional cytosolic proteins that are involved in the recognition of DNA 
viruses. A DNA binding protein, named DNA-dependent activator of IFN-regulatory 
factors (DAI), Z-DNA binding protein 1 (ZBP1), or DLM-1, binds cytosolic DNA 
inducing type I IFN and other genes involved in innate immunity 147,148.  Accordingly, 
RNA interference of mRNA for DAI in cells inhibits DNA-mediated antiviral responses.  
Furthermore, NALP3, a component of the cytosolic molecular complex termed the 
inflammasome, has been shown to recognize adenoviral DNA, inducing activation of 
caspase 1 and maturation of pro-interleukin-1β in macrophages 149. Correspondingly, 
mice lacking NALP3 or its signaling adaptor, ASC, display reduced innate inflammatory 
responses to adenovirus particles.  Even more recent studies have suggested that Aim2 
also recognizes DNA virus infection150.  Similar to NALP3, Aim2 activates the 
inflammasome pathway leading to IL-1β production.  Cells are also known to produce 
type I IFN in response to cytoplasmic dsDNA151.    The initial sensor in this pathway is 
currently unknown, however, STING is known to play a role in the downstream signaling 
pathway152.  The discovery of these sensors has provided further insight into the innate 
response against DNA viruses. 
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 Besides RLR and TLR classes of sensors, other proteins are known to detect viral 
products and contribute to the immune response, especially RNase L and protein kinase R 
(PKR). RNase L has recently been reported to be involved in the RLR response to viral 
nucleic acids 153.  It is proposed that 2’,5’-linked oligoadenylate generated by viral 
infection activates RNase L to cleave self RNA into small RNA products, which are 
responsible for RLR signaling.  However, it is not yet known how these small self-RNAs 
are recognized by MDA5 and RIG-I. PKR has been shown to dimerize upon binding of 
dsRNA.  The activated PKR dimer phosphorylates eukaryotic initiation factor 2-a (eIF2-
a) which results in inhibition of translation, preventing viral replication 154.  Recent 
results indicate that PKR is also necessary for the stabilization of type I IFN mRNA 
transcripts155.  Like RLRs, RNase L and PKR are upregulated in response to type I IFN, 
demonstrating their important role in the pre-programmed antiviral response.  
 
The role of RLRs and TLRs in viral infection 
RLRs 
 Among the RLRs, ligand preferences appear to determine which virus is 
recognized by which sensor.  The current paradigm is that RIG-I recognizes RNA 
containing 5’-triphosphates, while MDA5 recognizes dsRNA. Therefore it is not 
surprising that RIG-I has been shown to detect Influenza A and B viruses, vesicular 
stomatitis virus (VSV), and some Flaviviruses (Japanese Encephalitis Virus and Hepatitis 
C Virus) 112,156,157. Likewise, MDA5 detects picornaviruses such as encephalomyocarditis 
virus (EMCV), Mengo virus and Theilers virus 112,113.  These viruses contain a 5’ VPg 
cap instead of 5’triphosphate and make large amounts of dsRNA during replication.  
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However, other results do not neatly fit this paradigm.   RIG-I and MDA5 play redundant 
roles in the recognition of West Nile Virus 158, Dengue virus, 157 paramyxovirus, and 
reovirus 157, most of which contain 5’triphosphates.  In addition, although sendai virus 
has been shown to activate RIG-I, it encodes for a protein, the V protein, that is a specific 
inhibitor of MDA5 159.  Furthermore, murine hepatitis virus, a member of the coronavirus 
family that does not contain VPg has recently been shown to be recognized by MDA5160.  
One explanation is that although RIG-I preferentially recognizes 5-triphosphates and 
polyuridine rich regions, it can also recognize short dsRNA, while MDA5 recognizes 
long dsRNA 110. The ability of MDA5 and Rig-I to specifically detect certain viruses, 
while also detecting common pathogens illustrates the need for multiple sensors to 
recognize and control the wide variety of viral pathogens.  
 
TLRs 
 Compared to the RLRs, the role of TLRs in anti-viral responses is more intricate 
161,162.  TLR3 was originally shown to detect dsRNA127.  Accordingly, TLR3 has been 
implicated in the detection of several RNA viruses such as EMCV 163, CVB 70,  RSV 
164,165, West Nile Virus 166, and Punta Toro Virus 167. However, in another study TLR3 
did not contribute to viral pathogenesis in vesicular stomatitis virus (VSV), lymphocytic 
choriomeningitis virus (LCMV) and reovirus infections 168.  In addition, TLR3 has been 
implicated in recognition of DNA viruses. TLR3-deficient mice are more susceptible to 
MCMV infection than wild type mice169 and have defective T cell responses to HSV170.  
Thus, TLR3 may recognize not only RNA viruses, but also DNA viruses, most likely 
through RNA intermediates that are generated during viral replication.  
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 TLR7 has been shown to contribute to the detection of RSV, Sendai virus, 
influenza, HIV, VSV, and Coxsackie virus B3 (CVB3) 171, while TLR8 has been 
implicated in detection of influenza and paramyxovirus as well as HIV 129,146,172.  TLR9 
plays a role in recognition of Herpes Simplex virus and cytomegalovirus infection 169,173-
175.  TLR2 and 4 have been shown to play a role in the recognition of enveloped viruses.  
Both Herpesviruses, which contain a DNA genome, and RSV, which has a ssRNA 
genome, have been reported to be recognized by these sensors 176-178.  In summary, TLR7 
and 8 recognize ssRNA viruses, while TLR9 recognize DNA viruses.  TLR2 and 4 
recognize enveloped viruses, while TLR3 plays a role in recognition of both RNA and 
DNA viruses.  Overall, TLR viral specificities exhibit a significant overlap with those of 
RLRs.   
 
Pattern recognition receptors in human disease  
 Recent studies have implicated the dsRNA sensors MDA5 and TLR3 in human 
diseases.  Genome-wide analysis of single nucleotide polymorphisms (SNPs) identified a 
polymorphism in the gene encoding human MDA5, interferon induced helicase 1 (Ifih1), 
that is associated with an increased risk of T1DM179.  This polymorphism, A946T, is 
located near the N-terminus of the protein in an area that has been suggested to be a 
regulatory region in Rig-I and LGP-2.  This suggested that a genetic predisposition to 
T1DM may occur from an altered capacity to either detect viral infection or regulate IFN 
production through MDA5.  More recent studies indicate that very rare polymorphisms in 
Ifih1, which result in inability to produce IFN in response to virus or dsRNA, are 
protective for T1DM180,181.  This strengthens the link between viruses and diabetes and 
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suggests that IFN production by MDA5 may be a pathogenic instigator of T1DM.  
Meanwhile, another recent human study demonstrated that a dominant negative form of 
TLR3 causes susceptibility to neonatal Herpes Simplex-1 Encephalitis (HSE) 182.  This 
report indicates that TLR3 plays a role in protection in humans from viral infections, 
although whether TLR3 signaling is important for additional viruses remains to be seen. 
 
Conclusions 
 PRRs such as MDA5 and TLR3 play important roles in control of viral infection 
and have been implicated in human diseases.  Although much has been learned about the 
downstream signaling pathways and molecular ligands associated with these proteins, 
how they function in vivo remains poorly understood.  In this study, we will describe the 
investigation of MDA5 and TLR3 function in several in vivo systems.  Chapter 2 focuses 
on understanding how MDA5 and TLR3 control MNV-1 infection.  In Chapter 3, we 
make use of an EMCV infection model to study the role of MDA5 and TLR3 in 
myocarditis and diabetes.  Chapter 4 describes how MDA5 and TLR3 contribute distinct 
functions in NK cell activation by dsRNA.  Finally, Chapter 5 will describe how this 
work has contributed to our knowledge of how MDA5 and TLR3 function in vivo as well 
as potential applications for future studies. 
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Figure Legends 
 
Table 1.1.  Diseases Caused by Picornavirus and Calicivirus Family Members  
 
List of common diseases caused by picornaviruses and caliciviruses. 
 
 
Figure 1: Cytoplasmic and Endosomal Sensors of Viral Nucleic Acids 
 
This figure illustrates the detection of viral products by RLR and TLR family members 
and the downstream signaling pathways leading to IFN and inflammatory cytokine 
production.  
It has been published in: 
McCartney SA, Colonna M.  Viral Sensors: diversity in pathogen recognition.  Immunol 
Rev. 2009 Jan; 227(1):87-94. 
Reprinted with permission.  Copyright 2009. 
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Table 1.1: Diseases Caused by Picornavirus and Calicivirus Family Members 
Virus Disease 
Picornaviruses  
Poliovirus Poliomyelitis 
Coxsackievirus A Hand Foot and Mouth Disease, 
Meningitis, Conjunctivitis 
Coxsackievirus B Myocarditis, diabetes 
Echovirus Myocarditis, Meningitis 
Rhinovirus Common cold 
Hepatitis A virus Hepatitis 
Foot and Mouse Disease Virus Foot and Mouth Disease 
Encephalomyocarditis Virus Myocarditis, Encephalitis 
  
Caliciviruses  
Norwalk virus (norovirus) Gastroenteritis 
Sapporo virus Gastroenteritis 
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Figure 1.1 
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CHAPTER 2 
 
MDA5 Recognition of a Murine Norovirus 
 
 
 
 
 
 
This chapter has been published as: 
McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, Colonna M. MDA-5 
Recognition of a Murine Norovirus. PLoS Pathog 4(7), Jul 2008: e1000108. 
doi:10.1371/journal.ppat.1000108 
 
Reprinted with permission 
Copyright 2008.  
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Abstract 
Noroviruses are important human pathogens responsible for most cases of viral epidemic 
gastroenteritis worldwide.  Murine norovirus-1 (MNV-1) is one of several murine 
noroviruses isolated from research mouse facilities and has been used as a model for 
human norovirus.  MNV-1 infection has been shown to require innate immunity for 
clearance, however, the initial host protein that recognizes MNV-1 infection is unknown.  
Because noroviruses are RNA viruses, we investigated whether MDA5 and TLR3, 
cellular sensors that recognize dsRNA, are important for the host response to MNV-1.  
We have shown that MDA5 but not TLR3 deficient dendritic cells(DC) have a defect in 
cytokine response to MNV-1.  In addition, MNV-1 replicates to higher levels in MDA5 -
/- DCs as well as in MDA5 -/- mice in vivo. This is the first demonstration of an innate 
immune sensor for norovirus. Knowledge of the host response to MNV-1 may provide 
keys for prevention and treatment of the human disease. 
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Author Summary 
 Gastroenteritis is a common disease in both developed and developing countries.  
The two main causes of this affliction are bacteria and viruses.   The primary viruses 
implicated in gastroenteritis are a family of viruses called noroviruses, which include 
Norwalk virus, notorious for several recent outbreaks on cruise ships.  We are interested 
in how the innate immune system detects viral infection and signals the body to respond 
to the threat.  To learn more about this we studied two classes of proteins, both of which 
are thought to detect signs of viral infection.  We discovered that one of these proteins, 
Melanoma differentiation associated protein-5 (MDA-5), is responsible for detecting a 
mouse norovirus that is similar to the human pathogen.  These findings allow us to better 
understand the pathogenesis of norovirus infection and may provide clues for controlling 
the human disease.
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Introduction 
Norwalk virus and other human noroviruses are common human pathogens responsible 
for most of the nonbacterial epidemic gastroenteritis in both developed and developing 
countries[Estes, 2006 #6; Widdowson, 2005 #12; Lopman, 2004 #10; Fankhauser, 1998 
#8; Mead, 1999 #11].  In humans, norovirus infection results in vomiting, diarrhea, fever, 
malaise, and abdominal pain within 24 hours after infection.  These symptoms usually 
clear within 48 hours, but the virus can persist for 3-6 weeks post-infection[Dolin, 2004 
#9; Graham, 1994 #23].  Until recently the lack of ability to culture the virus has 
prevented us from investigating its pathogenicity.  The discovery and subsequent culture 
of murine norovirus-1 (MNV-1) has led to advances in understanding of both the viral 
lifecycle as well as the host response to infection[Wobus, 2004 #2; Karst, 2003 #19].   
 Noroviruses are in the Calicivirus family and are nonenveloped viruses containing 
a single-stranded positive-sense RNA genome.  This genome is covalently linked at the 
5’ end to the viral nonstructural protein VPg[Green, 2001 #31].  It encodes four open 
reading frames (ORFs)[Jiang, 1993 #20; Lambden, 1993 #21; Clarke, 2000 #22; 
Thackray, 2007 #1]. ORF1 encodes a polyprotein that is cleaved into at least six 
nonstructural proteins by the viral 3C-like protease[Blakeney, 2003 #43; Liu, 1996 #45; 
Liu, 1999 #46; Sosnovtsev, 2006 #44].  ORF2 encodes the major capsid protein, viral 
protein 1[Prasad, 1999 #47; Jiang, 1993 #20], while ORF3 encodes the small basic 
protein, viral protein 2[Bertolotti-Ciarlet, 2002 #48; Glass, 2000 #49].  OFR4 was 
recently discovered and has yet to be characterized[Thackray, 2007 #1].  
 The rapid clearance of MNV-1 infection indicates an important role for the innate 
immune system, since clearance occurs before the typical initiation of adaptive 
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immunity[Mumphrey, 2007 #5].  Previous work has revealed that MNV-1 infection of 
mice lacking either the type I and type II interferon (IFNα/β/γ) receptors or the STAT-1 
molecule is lethal [Mumphrey, 2007 #5; Karst, 2003 #19].  Several proteins are known to 
initiate the IFN response to viruses[Takeuchi, 2007 #63], including Toll-like receptors 
(TLR)[Iwasaki, 2004 #42], Rig-I-like helicases (RLH)[Sumpter, 2005 #38; Pichlmair, 
2007 #51], PKR[Garcia, 2007 #32], and RNase L[Malathi, 2007 #15].  However, the 
initial sensor responsible for recognition of noroviruses and subsequent activation of 
cytokine response has not been determined.   
TLRs are located on the plasma membrane and in endosomal compartments. Among the 
TLRs, TLR 7 and 8 recognize ssRNA[Lund, 2004 #36; Heil, 2004 #41; Diebold, 2004 
#52], TLR9 recognizes DNA[Bauer, 2001 #39; Hemmi, 2000 #53], while TLR3 signals 
in response to dsRNA[Alexopoulou, 2001 #54].  The RLHs are cytoplasmic sensors 
located intracellularly[Pichlmair, 2007 #51], which include Rig-I and MDA-5[Takeuchi, 
2007 #24] [Fujita, 2007 #35; Yoneyama, 2004 #55] and signal through IPS-
1/MAVS/Cardiff/VISA[Xu, 2005 #61; Meylan, 2005 #60; Sun, 2006 #59]}[Perry, 2005 
#62].  Rig-I has recently been shown to preferentially recognize 5’-phosphorylated 
RNA[Hornung, 2006 #26; Pichlmair, 2006 #27], while MDA5 responds to dsRNA 
[Yoneyama, 2005 #37].  Recently it has been shown that the lack of Rig-I does not confer 
susceptibility to human norovirus in vitro[Guix, 2007 #7].  Because MDA5[Loo, 2008 
#17; Kato, 2006 #13; Gitlin, 2006 #18; Fredericksen, 2008 #58],  and possibly TLR3 
[Edelmann, 2004 #56; Wang, 2004 #57] have been shown to play a role in host response 
to other RNA viruses we investigated if these sensors might be involved in MNV-1 
recognition. 
 46 
Results 
MDA-5 is required for cytokine response to MNV-1 by Bone Marrow-Derived DC.  
Previous studies have shown a requirement for the type I IFN response for control of 
MNV-1 infection[Wobus, 2004 #2].  Since both MDA5 and TLR3 have been shown to be 
involved in type I IFN and cytokine signaling in response to infection with other viruses, 
we were interested to see if they may play a role in MNV-1 infection.   
 MNV-1 infection has a limited cell tropism- infecting only DC and macrophage 
lineages in vitro[Wobus, 2004 #2; Ward, 2006 #50].   In order to test whether the MDA5 
or TLR3 sensors were important, BMDCs from Wild Type as well as TLR3 -/- and 
MDA5 -/- mice were cultured for 7 days and then stimulated with various MOI of MNV-
1 isolates.  After 24 hours supernatants from the in vitro infections were harvested and 
tested for cytokine production.   
Interestingly, although WT and TLR3 DCs produced similar levels of IFNα and 
inflammatory cytokines in response to MNV stimulation, MDA5 deficient DCs produced 
significantly less IFNα, IL-6 , MCP-1 and TNFα (figure 1) and IFNβ (data not shown).  
This indicates a role for MDA5 in the detection of MNV-1 infection.   
MNV-1 replicates more efficiently in MDA-5 deficient DCs.  Because the MDA5 -/- 
BMDCs had a defect in cytokine response to MNV-1, we wanted to test if this deficiency 
had an effect on the course of viral infection.  To address this issue, we infected BMDCs 
in vitro with MNV-1 and harvested samples at 6-hour time-points post-infection.  The 
infections were done at a saturating and non-saturating MOI to test for effects on viral 
replication and spreading. 
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Viral titers were identical in WT and MDA5 KO mice up to 12 hours post-infection at a 
saturating MOI (figure 2a).  However, starting at 18 hours pi, titers from MDA5 KO 
BMDCs began to increase over WT BMDCs, and leveled out to a 1-log difference at 24 
and 48 hours. At a lower MOI there was no significant difference between viral titers in 
the WT and KO cells until the 48-hour time point (figure 2b).  At both MOIs the kinetics 
of MNV-1 infection appears similar in WT and MDA5 -/- BMDCs; the difference mainly 
appears to be in the total amount of viral replication seen in the KO BMDCs.  These 
results as well as the defect in cytokine response seen previously provide further evidence 
for the role of type I IFN (IFNα IFNβ) in preventing MNV-1 growth. 
MDA5 limits MNV-1 replication in vivo.  MNV-1 infection naturally occurs after fecal-
oral transmission[Wobus, 2004 #2].  In order to show that MDA5 plays a role in MNV-1 
detection in vivo we infected WT or MDA5 -/- mice with MNV-1.CW3 perorally.  
Organs were then harvested from infected as well as mock-infected mice on days 1, 3, 
and 5 post-infection and viral titers were determined for each sample.  
     At d3 post-infection MDA5 KO animals had a one log increase in viral titers 
compared to wild type animals in the mesenteric lymph nodes, spleen, and proximal 
intestine (figure 3).  Minimal or negative titers were seen in distal intestine, and stool as 
well as liver and lung (data not shown) by viral plaque assay in both WT and MDA5 KO 
animals, indicating that MNV-1 infection remained locally contained.  Consistent with 
lack of systemic infection, serum samples taken at d1, 3, and 5 timepoints post-infection 
were found to be negative for IFNα and IFNβ (data not shown).  Organs harvested at d1 
and d5 also contained minimal detectable levels of MNV-1 in both WT and MDA5 KO 
mice indicating that the infection developed and was cleared in the timeframe that has 
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been reported earlier[Mumphrey, 2007 #5].  Similar to our in vitro data, the kinetics of 
MNV-1 infection is similar in WT and MDA5 -/- mice in vivo, while there is a significant 
increase in maximum titers in the KO animals.  This suggests that MDA5 controls the 
amplitude of infection. 
MDA-5 recognizes replication competent viral RNA.  Although MDA5 detects 
norovirus, it is unclear which RNA feature is essential for recognition.  Rig-I recognizes 
viruses through 5’-phosphorylation, however, in norovirues this feature is absent because 
of a 5’ VPg cap[Green, 2001 #31].  To test whether 5’ RNA configuration is essential for 
MDA5 recognition we infected BMDCs with MNV and then harvested the total RNA 
from infected as well as mock-infected cells before peak infection to isolate potential 
intermediates.  BMDCs from WT or MDA5 deficient mice were then stimulated with the 
harvested RNA, as well as RNA treated with calf intestinal phosphatase (CIP,) which 
removes 5’ phosphates, and proteinase K (PK), which degrades proteins including VPg 
and prevents viral replication in vitro[Guix, 2007 #7]. 
 Both WT and MDA5 -/- DCs produced limited inflammatory cytokines in 
response to mock-infected RNA, however, WT but not KO BMDCs produced large 
amounts of TNFα and IFNβ in response to RNA from MNV-infected cells (figure 4).  
CIP treatment of the RNA had no significant effect on cytokine production in either cell 
type, as predicted by the existence of VPg instead of 5’ phosphorylation.  However, the 
addition of PK to the RNA abrogated the cytokine response in WT BMDCs.  This 
suggests that MDA5 does not recognize naked viral RNA, but either directly recognizes 
RNA linked to VPg  or recognizes a RNA product generated during viral replication.  
Because MDA5 has been previously shown to recognize uncapped poly I:C[Kato, 2006 
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#13; Gitlin, 2006 #18], it is most likely that the PK effect reflects the requirement for 
viral replication and the subsequent generation of RNA species that are recognized by 
MDA5. 
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Discussion 
We have provided the first description of an initial sensor of norovirus infection.  MDA5 
recognizes MNV-1 and stimulates antigen presenting cells to produce type I interferon as 
well as IL-6, MCP-1, and TNFα that function to recruit other immune cells as well as 
activate antiviral pathways in host cells.  Deficiency of this sensor results in lack of 
cytokine production as well as increased MNV-1 replication in deficient cells and mice.     
 It is interesting to note that although MDA5 deficient cells have a defect in IFNα 
production, the mice do not have as severe a phenotype as the IFNαβγR or Stat1 deficient 
mice.  These mice completely lose the ability to respond to IFN because they lack either 
its receptor or a critical downstream signaling molecule.  As a result these mice have 
widespread MNV-1 dissemination that often results in lethality.  The more mild 
phenotype seen in the MDA5 KO mice resembles that seen in the IFNαβR KO mice and 
likely results from the retained ability of IFNγ production.  Additionally, it is also 
possible that other sensors of viral products or cell damage are able to respond and trigger 
an IFN and cytokine response.  Further investigation is needed to determine if mice that 
are deficient in multiple nucleic acid sensors lack all ability to respond to MNV-1 and 
whether they therefore have a more severe phenotype.  Data from our lab and 
others[Guix, 2007 #7] from in vitro experiments suggest that TLR3 and Rig-I are 
unlikely candidates for additional MNV-1 sensors, but TLR7 remains to be tested, as 
does the role of other sensors in vivo. 
 Although the putative recognition structure for Rig-I has previously been 
determined[Hornung, 2006 #26; Pichlmair, 2006 #27], the RNA structure recognized by 
MDA5 in viral infection remains unclear.  We demonstrated that MDA5 recognition of 
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MNV RNA is abrogated by treatment with PK, which degrades VPg, preventing viral 
replication.  This suggests that MDA5 does not recognize naked RNA, but rather a RNA 
intermediate that is abundantly generated during replication.  Although we cannot rule 
out the possibility that MDA5 recognizes the VPg-RNA structure itself, this is unlikely 
because MDA5 is known to respond to poly I:C which has no protein cap.  Learning 
more about which viruses are recognized by MDA5 may provide hints as to what this 
protein recognizes.  This information could then be used to design adjuvants to 
manipulate the immune response for both vaccine design as well as in viral infection.   
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Materials and Methods 
Cell Lines. RAW264.7 cells were maintained in Dulbecco modified Eagle medium 
(DMEM) supplemented with 10% fetal calf serum (Hyclone), 100U penicillin/ml, 
100µg/ml streptomycin, 10 mM HEPES, and 2 mM L-glutamine. 
Bone Marrow-derived DC.  Bone marrow was flushed from the femurs of mice and 
cultured as described previously[Barchet, 2005 #28].  Briefly, cells were cultured in 
RPMI (Gibco) with 10% fetal calf serum (Hyclone), Glutamax, Na Pyruvate, Non-
Essential AAs, and Kanamycin for 7-8 days at 37 degrees. 
Mice.  MDA5 -/-  mice were described previously[Gitlin, 2006 #18]. For the infection 
studies mice backcrossed onto a pure 129/SVJ background were used.  Control WT mice 
were age and sex matched and were obtained from littermate controls and from Jackson 
Lab for 129/SVJ.  TLR3 -/- mice were kindly provided by Richard Flavell [Alexopoulou, 
2001 #29].  All mice were bred and housed in a pathogen free facility and regularly tested 
for MNV-1 antibodies. 
In vitro stimulations.  BMDCs were counted and plated at 200,000 cells/well in a 96 
well plate.  MNV-1 was added at various MOI to the cultures, or alternatively 500ng 
RNA was complexed with lipofectamine 2000 (invitrogen) and added according to 
manufactures instructions.  After 20-24 hours supernatants were harvested and stored at -
20 degrees until cytokine analysis.  IFNα and IFNβ levels from the supernatants were 
measured by ELISA (PBL Biomedical Laboratory, New Brunswick, NJ), while IL-6, 
MCP-1, and TNFα levels were determined by cytokine bead array (BD Biosciences). 
In vivo infections.  WT or MDA5 KO mice were infected perorally with 1X107 PFU 
MNV1.CW3[Thackray, 2007 #1] or mock-infected with media only. Three days post-
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infection the following organs were harvested and stored at -80 degrees until assayed: 
spleen, liver, mesenteric lymph node, lung, proximal intestine, distal intestine, stool, and 
serum. 
MNV-1 plaque assay.  Tissue samples were homogenized in 1 ml complete DMEM by 
bead beating with 1.0-mm zirconia/silica beads (BioSpec Products, Inc.).  Tissue 
homogenates were diluted 1:10 in complete DMEM and tested for viral titers by using a 
plaque assay that has been previously described [Wobus, 2004 #2].  Briefly, 2X106 
RAW264.7 cells were seeded into each well of six-well plates, and infected the next day 
with 10-fold dilutions of tissue homogenate in duplicate.  After a 1-hr infection, the 
inoculum was removed and wells were overlaid with 1.5% SeaPlaque agarose 
(Cambridge Biosciences) in complete minimal essential medium and incubated at 37C.  
After 48 hrs, a second overlay was added containing 1.5% SeaKem agarose (Cambridge 
Biosciences) and 0.01% neutral red in complete minimal essential medium.  After 8 hrs, 
plaques were then visualized. 
RNA preparation.  5*106 BMDC were infected with MNV-1 at MOI 1 or mock-infected 
for 10 hours.  Total RNA was harvested using the Genelute Total RNA Isolation Kit 
(Sigma).  Purified RNA was incubated with either 10 units Calf Intestinal Phosphatase 
(New England Bioloabs) in NEB buffer 2 or with 200µg/ml proteinase K (Sigma) in 
0.1M NaCl, 10mM Tris (pH 8), 1mM EDTA, 0.5% sodium dodecyl sulfate or left 
untreated for one hour at 37 degrees then precipitated with LiCl (Ambion), washed, and 
resuspended for stimulations. 
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Figure Legends 
Figure 2.1: MDA5 is required for cytokine response to MNV in vitro.  Bone marrow-
derived dendritic cells from wild type, TLR3 KO, or MDA5 KO mice were stimulated in 
vitro with MNV at the indicated MOI.  24 hours later, cell culture supernatants were 
harvested and examined for IFNα by ELISA or for IL-6, TNFα, and MCP-1 by cytokine 
bead array.  Data shown is the average of three independent experiments.  Statistical 
analysis was done using student’s t test where * = p<0.05, ** = p<0.01, and *** = 
p<0.001. 
 
Figure 2.2: MDA5 deficiency leads to increased MNV titers in vitro.  Bone marrow-
derived dendritic cells from wild type or MDA5 KO mice were infected with MNV at 
MOI 5 or 0.05.  Samples were taken at 6-hour time-points and stored at -80 degrees.  
Viral titers were determined in duplicate on RAW cells for each sample and statistical 
significance was determined using student’s t test.  Data shown is the average of four 
independent experiments. 
 
Figure 2.3: MNV replicates more efficiently in MDA5 KO hosts.  Wild type or MDA5 
deficient mice were inoculated perorally with 1X107 PFU MNV-1.CW3 or mock infected 
with media only.  Organs were harvested 3 days post-infection and viral titers of 
Mesenteric Lymph Node (MLN), Spleen , Proximal Intestine (prox intest), Distal 
Intestine (dist intest), and Stool were determined by viral plaque assay.  Statistical 
significance was calculated using the Mann Whitney test, and P values comparing 
infection between WT and MDA5 KO mice are as follows: MLN P<0.0001; Spl 
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P=0.0003; PI P=0.0002.  Mock-infected animals showed no detectable MNV-1 at all 
time-points tested.  Data shown is from at least 9 animals. 
 
Figure 2.4:  Proteinase K  and RNase abrogates MDA5 recognition of viral RNA.  
WT or MDA5 -/- BMDCs were stimulated with RNA from MNV infected or mock 
infected lysates that was treated with CIP, PK or untreated.  After incubation for 20 
hours, supernatants were harvested and cytokines analyzed with CBA and IFNβ ELISA.  
Data shown is from three independent experiments and statistics were calculated by 
student’s t test 
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Chapter 3 
RNA Sensors in Myeloid Cells Prevent Virus-Induced Diabetes 
 
 
 
 
 
This chapter has been submitted for publication as: 
McCartney SA, Vermi W, Lonardi S, Rossini C, Otero K, Calderon B, Gilfillan S, 
Diamond MS, Unanue ER, and Colonna M. RNA sensors prevent virus-induced diabetes 
in mice. 
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Abstract 
Viruses have long been implicated in the etiology of type I diabetes mellitus (T1DM).  
This association was further strengthened by the finding of genetic susceptibility to 
T1DM associated with polymorphisms in the human gene encoding MDA5, a dsRNA 
sensor involved in the recognition of viral infection.  In addition to MDA5, the 
endosomal dsRNA sensor TLR3 has also been implicated in animal models of diabetes 
and viral infection.  It has been suggested that these sensors may induce T1DM through 
the production of type I IFN in response to infection, which may lead to increased 
stimulation of autoimmune T cells.  In this study we addressed the relative contributions 
of MDA5 and TLR3 to the host response to picornavirus infection and diabetes using a 
model of encephalomyocarditis virus strain D (EMCV-D).  By analyzing EMCV-D 
infection in MDA5-/-, TLR3-/- and MDA5-/-TLR3-/- double knockout (DKO) mice we 
found that MDA5 and TLR3 have different impacts in the control of viral infection and 
tissue damage in heart and pancreas.  EMCV-D infection caused primarily heart damage 
in MDA5-/- mice but severe diabetes in TLR3-/- mice.   We further determined that the 
development of diabetes in the TLR3-/- animals was due to virus-induced β-cell damage 
rather than T cell-mediated autoimmunity, and resulted from the impaired capacity of 
hematopoietic cells, especially DC, to induce an early IFN-β response that restricts β-cell 
infection.  These findings indicate that IFN produced by dsRNA sensors limits diabetes 
induced by viral infection, and provides evidence that these proteins can be protective as 
well as pathogenic. 
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Introduction 
Innate immune responses to viruses depend on molecular sensors that promptly detect 
viral products and trigger the secretion of type I interferons, i.e. IFN-β and IFN-α 
(Takeuchi and Akira 2007). Two types of sensors detect double-stranded (ds) RNA 
generated during infection with RNA viruses: Toll-like receptor (TLR) 3 and RIG-I-like 
receptors (RLR). TLR3 senses the dsRNAs that reach the endosomal compartment due to 
the phagocytosis of virally infected cells(Kawai and Akira). RLRs include two IFN-
inducible helicases, MDA5 and RIG-I, which sense the dsRNAs that are generated in the 
cytoplasm during viral replication. MDA5 specializes in the detection of picornaviruses, 
whereas RIG-I senses most of the other RNA viruses(Yoneyama and Fujita 2009). These 
viral specificities depend on the ability of MDA5 and RIG-I to detect RNA molecules 
with different lengths, structures, and 5’ caps (Cui, Eisenacher et al. 2008; Kato, 
Takeuchi et al. 2008; Saito and Gale 2008; Takahasi, Kumeta et al. 2009).   
 
TLR3 deliver its intracellular signal through the adaptor TRIF, activating the 
transcription factor IRF3, which induces IFN-β production(Yamamoto, Sato et al. 2002). 
RIG-I and MDA5 signal through another adaptor, IPS-1, that activates IRF3 and IRF7, 
inducing both IFN-β and IFN-α production(Kawai, Takahashi et al. 2005; Meylan, 
Curran et al. 2005; Seth, Sun et al. 2005; Xu, Wang et al. 2005). A third RLR, Lgp2, 
detects dsRNA but does not contain signaling domains and is thought to positively 
regulate MDA5 and negatively regulate RIG-I (Satoh, Kato et al.; Rothenfusser, 
Goutagny et al. 2005; Venkataraman, Valdes et al. 2007). Type I IFNs induce an antiviral 
state in uninfected cells and promote apoptosis of infected cells, limiting viral replication 
 69 
and spreading(Garcia-Sastre and Biron 2006). Moreover, type I IFNs promote subsequent 
NK cell, T cell and B cell responses(Stetson and Medzhitov 2006), facilitating complete 
viral clearance.  
 
Type I diabetes (T1DM) is an autoimmune disease caused by selective destruction of β-
cells of the endocrine pancreas by autoreactive T cells. Although predisposing genetic 
factors, particularly MHC class II, play a predominant role in the pathogenesis of T1DM, 
clinical (Yoon, Austin et al. 1979; Hyoty, Hiltunen et al. 1995; Andreoletti, Hober et al. 
1997; Ylipaasto, Klingel et al. 2004) and experimental (Craighead and McLane 1968; 
Yoon, McClintock et al. 1980; Guberski, Thomas et al. 1991)studies have suggested that 
viral infections may contribute to T1DM, particularly infections by RNA viruses such as 
Coxsackie B4 and enteroviruses. These viruses may induce T1DM by causing β-cell 
damage and subsequent release of autoantigens that induce and/or trigger autoreactive T 
cells(Horwitz, Ilic et al. 2002). Additionally, excessive type I IFN and cytokine response 
to viral infection can activate and attract pre-existing autoreactive T cells that have 
escaped thymic selection (von Herrath 2009). Consistent with a diabetogenic role of type 
I IFN response to viruses, genetic studies have recently showed that resistance to T1DM 
is highly associated with MDA5 polymorphisms that reduce response to dsRNA 
(Nejentsev, Walker et al. 2009; Shigemoto, Kageyama et al. 2009). Additional studies 
demonstrated that TLR3 activation by synthetic dsRNA precipitate disease in mouse 
models of T1D (Wen, Peng et al. 2004; Lang, Recher et al. 2005). Altogether, these 
studies suggest that RNA sensors may contribute to the incidence T1DM. 
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In this study we addressed the relative contributions of MDA5 and TLR3 in host response 
to picornavirus infection and diabetes in the model of encephalomyocarditis virus strain 
D (EMCV-D). EMCV-D is picornavirus family member that has preferential tropism for 
pancreatic β-cells, and can induce diabetes in selective mice strains such as 
DBA/2(Gaines, Kayes et al. 1986; Cerutis, Bruner et al. 1989). EMCV-D, like other 
EMCV strains, also induces myocarditis. The role of MDA5 and TLR3 in EMCV 
infection has been matter of debate. Initial studies indicated that MDA5 is essential for 
protection from EMCV infection, while TLR3 was dispensable (Gitlin, Barchet et al. 
2006; Kato, Takeuchi et al. 2006); however, a subsequent study suggested that TLR3 
provides protection from EMCV-induced myocarditis (Hardarson, Baker et al. 2007). By 
analyzing EMCV-D infection in MDA5-/-, TLR3-/- and MDA5-/-TLR3-/- double knockout 
(DKO) mice we found that MDA5 and TLR3 have different impacts in the control of 
viral infection and tissue damage in heart and pancreas. EMCV-D infection caused 
mainly heart damage in MDA5-/- mice and diabetes in TLR3-/- mice. Remarkably, 
diabetes was due to virus-induced β-cell damage rather than T cell-mediated 
autoimmunity, and depended on the impaired capacity of hematopoietic cells, especially 
DC, to induce an early IFN-β response that restricts β-cell infection. These results 
indicate that MDA5 and TLR3 have different impacts on anti-viral responses in distinct 
organs because they have different cellular distribution and mediate type I IFN responses 
of different magnitude and kinetics.  Moreover, RNA sensors are not always 
diabetogenic; in fact their impact depends on the pathogenetic mechanism of diabetes. 
While in autoimmune diabetes engagement of RNA sensors by viruses may unveil or 
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trigger a latent autoimmune condition, in diabetes caused by direct viral damage of β-
cells, a normal function of RNA sensors in innate immune cells is essential for protection. 
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Results 
Both MDA5 and TLR3 contribute to survival from EMCV-D infection 
To evaluate the roles of MDA5 and TLR3 in the response to EMCV-D, we infected WT, 
MDA5-/-, TLR3-/- and DKO mice with EMCV-D. All mice were on a C57BL/6 
background. Similar to previous reports, WT C57Bl/6 mice survived EMCV-D infection; 
however, MDA5-/- mice were highly susceptible and died on day 5 post-infection (PI) 
(Fig. 1).  TLR3-/- mice were also more susceptible to EMCV-D than WT mice, but less 
susceptible than MDA5-/- mice, dying on average at day 20 PI with a proportion of mice 
surviving infection. The contribution of TLR3 to anti-EMCV-D defense was further 
confirmed by the more severe sensitivity of DKO mice to EMCV-D compared to MDA5-
/- mice.  DKO mice died at day 2 PI (Fig. 1), or at day 3 PI with an extremely low 
inoculum of 1 PFU/mouse (data not shown).  These data demonstrate that both MDA5 
and TLR3 contribute to the containment of EMCV-D infection in vivo although MDA5 
appears to have a predominant role over TLR3. 
 
Infection of MDA5-/- and TLR3-/- mice with EMCV-D results in different heart and 
pancreatic diseases 
Previous studies have implicated MDA5 (Kato, Takeuchi et al. 2006) and TLR3 
(Hardarson, Baker et al. 2007) in protection from EMCV-induced viral myocarditis using 
different strains of EMCV. To test the relative contributions of MDA5 and TLR3 to the 
protection of heart from EMCV-D, we measured serum troponin in WT, MDA5-/-, TLR3-
/-, and DKO mice after infection, which reflects the extent of cardiac damage. Similar to 
previous findings (Kato, Takeuchi et al. 2006), MDA5-/- mice had highly elevated 
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troponin levels by day 4 (Fig. 2A). Correspondingly, the hearts of MDA5-/- mice showed 
high EMCV-D titers, marked immunoreactivity for EMCV-D antigens and histological 
evidence of myocarditis at this time-point (Fig. 2B and Fig. S1). TLR3-/- mice showed 
milder signs of heart infection than MDA5-/- mice. Troponin levels were normal with the 
exception of few TLR3-/- mice with elevated troponin at day 7. Heart viral titers were 
slightly higher than those of WT mice at all time points, and histopathology was modest 
(Fig. 2 and Fig. S1).  The contribution of TLR3 to anti-EMCV-D response in the heart 
became more evident in the DKO mice, which showed earlier increase in troponin levels, 
higher levels of EMCV replication in the heart and stronger immunostaining for EMCV 
antigens than MDA5-/- mice. These results indicate that MDA5 plays a dominant role in 
the protection from EMCV-D-induced myocarditis, whereas TLR3 contribution is 
secondary. 
 
EMCV-D is also known to infect the pancreas, particularly the β-cells of the pancreatic 
islets, leading to the development of diabetes in susceptible mouse strains like DBA/2 
(Gaines, Kayes et al. 1986). C57Bl/6 mice are normally resistant to EMCV-induced 
diabetes, and accordingly WT mice maintained normal serum glucose levels after 
EMCV-D infection (Fig. 3A). Additionally, WT mice showed no increase of the 
pancreatic enzymes amylase or lipase in the serum, suggesting lack of significant damage 
of exocrine pancreas (Fig. 3B). EMCV-D titers in the pancreas were increased at day 1-3 
PI but were cleared within a week. Deficiency of MDA5 was not as harmful for the 
pancreas as it was for the heart. MDA5-/- mice showed no detectable hyperglycemia and a 
slight increase in serum amylase and lipase at day 2 and 4 PI (Fig. 3 and data not shown). 
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Viral titers were similar to those of WT animals at day 1 PI, but increased at day 2 PI and 
remained elevated until day 4-5 PI, when most of the mice died (Fig. 3). Thus, MDA5 is 
essential for EMCV-D control at late rather than early timepoints, most likely because 
MDA5 expression must be induced by type I IFN. Similar to MDA5-/- mice, TLR3-/- mice 
showed minimal increase in amylase or lipase in the serum (Fig. 3). Surprisingly, 
however, TLR3-/- mice developed marked hyperglycemia by day 5 (Fig. 3A) and by day 
7 had almost undetectable islet mass as assessed by hematoxylin-eosin staining (Fig. S2). 
TLR3-/- mice showed higher viral titers in the pancreas at days 1 and 2 PI compared to 
WT and MDA5-/- mice, but normal clearance of EMCV-D by day 7.  Thus, TLR3 plays 
as role in the early control of EMCV-D infection, which appears to be essential for the 
protection of the endocrine pancreas.  
 
Finally, examination of pancreas of DKO mice demonstrated an impressive increase of 
serum levels of amylase and lipase as compared to WT mice, which was paralleled by a 
large increase in viral titers and extensive destruction of pancreatic architecture in both 
the exocrine and endocrine tissue on day 2 (Fig. 3A and S2). This virus-induced 
pancreatitis is likely to be the major cause of the death of DKO mice at day 2 PI, given 
the comparatively moderate defect in the heart at this timepoint. Despite a severe EMCV 
infection of the islets, DKO mice did not develop detectable hyperglycemia, perhaps due 
to the concomitant pancreatitis that is rapidly followed by death. Altogether, these results 
reveal that MDA5 and TLR3 play partially redundant roles in EMCV-D control in the 
exocrine pancreas, such that only DKO mice develop an overt pancreatitis. However, 
TLR3 is essential to prevent damage of pancreatic islets, perhaps because of its unique 
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role in the early control of EMCV-D infection. MDA5 does control EMCV-D infection at 
later timepoints, but it may be too late to effectively protect endocrine pancreas. Overall, 
the development of three completely different disease outcomes after infection with the 
same dose of EMCV-D demonstrates that MDA5 and TLR3 have different impacts on 
anti-viral responses in distinct organs. 
 
EMCV-D-induced β-cell damage in TLR3-/- mice is T cell-independent  
T1D is the result of the autoimmune destruction of pancreatic islets by the autoreactive T 
cells. EMCV-D-induced diabetes in TLR3-/- mice, however, was not paralleled by an 
obvious T cell infiltration of pancreatic islets at any time after infection (data not shown), 
making the involvement of an autoimmune mechanism unlikely. At early time points, 
pancreatic islets of TLR3-/- mice showed marked staining for viral antigens compared to 
WT mice supporting the viral titer data (Fig. 4A). Additionally, islets of TLR3-/- mice 
showed marked apoptosis as assessed by staining for caspase 3 (Fig. 4B), and a robust 
infiltrate of myeloid cells that was consistent with the presence of 
monocytes/macrophages and/or dendritic cells recruited from either the blood or local 
tissue (Fig. 4C). In contrast, WT mice showed only a limited increase of myeloid cells 
mostly located around but not within the pancreatic islets. Altogether, the extensive viral 
infiltration and apoptosis in the pancreatic islets of TLR3-/- mice suggest that diabetes is 
due to failure to control local infection. 
 
TLR3 must be present in the hematopoietic compartment to prevent EMCV-D-
induced diabetes 
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We next asked whether TLR3 and MDA5 play their protective roles against EMCV-D 
infection by acting directly in the infected tissues or in the innate immune system. To test 
this hypothesis, we generated bone marrow chimeras between WT and MDA5-/- mice as 
well as between WT and TLR3-/- mice and measured survival and blood glucose after 
EMCV-D infection. Survival curves showed that chimeras containing MDA5-/- 
hematopoietic cells and WT stroma (MDA5->WT) were resistant to EMCV-D infection, 
while WT->MDA5-/- chimeras were highly susceptible to infection similar to MDA5-/- 
mice. Conversely, TLR3-/-->WT chimeras were more sensitive to EMCV-D infection 
than WT->TLR3-/- chimeras, although not as susceptible as WT->MDA5-/- chimeras (Fig. 
5A). These results demonstrate that the overall resistance to EMCV-D infection is largely 
dependent on MDA5 function in radio-resistant stromal tissues, while TLR3 contributes 
to the anti-EMCV-D defense in part, especially in hematopoietic cells. However, the 
analysis of blood glucose after EMCV-D infection revealed a quite different picture of 
MDA5 and TLR3 impact on the protection of pancreatic islets. TLR3-/-->WT chimeras 
developed diabetes after EMCV-D infection, whereas WT->TLR3-/- chimeras as well as 
MDA5->WT and WT->MDA5-/- chimeras were protected from diabetes (Fig. 5B). Thus, 
protection of endocrine pancreas from EMCV-D infection and diabetes is largely 
dependent on TLR3 expression in the radio-sensitive hematopoietic compartment. 
 
Early IFN-β  response through TLR3-IRF3 prevents EMCV-D-induced diabetes 
The selective impact of TLR3 on the control of EMCV-D-induced diabetes indicated that 
TLR3 has a special role in the response to the infection. We noticed that TLR3-/- mice 
exhibit higher viral titers than WT and MDA5-/- mice at early timepoints PI (see Fig. 3C). 
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In contrast, MDA5-/- mice showed higher viral titers than WT and TLR3-/- mice at late 
timepoints (see Figs. 2B and 3C). Thus, we hypothesized that TLR3 may prevent EMCV-
D-induced diabetes through the induction of type I IFN early after infection. To test this 
hypothesis we measured type I IFN in the serum of infected mice using a sensitive 
bioassay. In the MDA5-/- mice type I IFN was severely reduced as compared to WT mice; 
the residual type I IFN detected in MDA5-/- mice was dependent on TLR3, since no type I 
IFN was observed in the serum of DKO mice (Fig. 6A). Thus, the quantitative impact of 
MDA5 and TLR3 on type I IFN response is different, MDA5 being responsible for most 
of it. MDA5 and TLR3 also contributed differently to the kinetics of type I IFN response. 
While type I IFN was detected as early as 15 hours after EMCV-D infection in the serum 
of WT and MDA5-/- mice, in TLR3-/- mice was detected only later, suggesting that TLR3 
induces an early IFN response to EMCV-D that is essential to protect β-cells.   
 
TLR3-mediated signals activate the transcription factor IRF3, which binds the IFN-β 
promoter inducing IFNβ production(Honda, Takaoka et al. 2006).  If TLR3-mediated 
IFN-β production is necessary to protect from EMCV-D-induced diabetes, one would 
expect that mice lacking IRF3 or IFN-β would also develop diabetes after EMCV-D 
infection.  To test this, we infected IRF3-/- and IFN-β-/- mice with EMCV-D and 
measured blood glucose.  Both IRF3-/- and IFN-β-/- mice developed hyperglycemia after 
infection. However, both knockout mice were much more susceptible to EMCV-D and 
died earlier than TLR3-/- mice (Fig. 6B,C), most likely because a global defect of IRF3 
and IFN-β impairs more anti-viral pathways than that triggered by TLR3 only. Since 
TLR3 must be expressed in the hematopoietic compartment to protect from diabetes, we 
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hypothesized that a defect of IRF3 and IFN-β limited to the hematopoietic compartment 
may be sufficient to induce diabetes. To test this, we created IRF3-/-->WT and IFN-β-/--
>WT bone marrow chimeras, which were then infected with EMCV-D.  Both chimeras 
developed hyperglycemia after infection, and had a mild survival defect similar to the 
TLR3-/- chimeras (Fig. 6D,E).  This data strongly supports the hypothesis that early IFN-
β production by hematopoietic cells through the TLR3-IRF3 pathway is critical for 
protection from EMCV-D-induced diabetes.   
 
Dendritic cells are necessary for protection from EMCV-D-induced diabetes 
We finally investigated which hematopoietic cell types are implicated in the TLR3-
mediated control of EMCV-D-induced diabetes. We had previously observed the 
accumulation of myeloid cells around the islets of WT mice after EMCV-D infection (see 
Fig. 5). Interestingly, these cells expressed TLR3 (Fig. 7A), suggesting that they may be 
responsible for the early type I IFN secretion that protects β-cells from EMCV-D. We 
asked whether protective myeloid cells are macrophages or DC. To directly assess the 
involvement of macrophages in preventing virus-induced diabetes, we infected WT mice 
with EMCV-D after the injection of clodronate-containing liposomes, which deplete 
macrophages(Van Rooijen 1989). Macrophage depletion increased susceptibility to 
EMCV-D infection as reflected by survival, but had no effect on diabetes induction in 
WT mice, suggesting that macrophages were dispensable for the protection of β-cells 
(Fig. 7B,C). To assess the involvement of DC in preventing virus-induced diabetes, we 
infected with EMCV-D CD11c-diphtheria toxin receptor (CD11c-DTR) transgenic mice, 
which can be depleted of DC by injection of diphtheria toxin.  DC-depleted mice were 
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not only highly susceptible to EMCV-D infection, but also developed diabetes, 
suggesting that DCs are critical for protection of β-cells from EMCV-D (Fig. 7D,E). 
Because DC activate cytotoxic lymphocytes such as NK cells and CD8 T cells through 
secretion of type I IFN, inflammatory cytokines and through cell-cell interaction, we 
asked whether cytotoxic cellular responses contribute to EMCV-D clearance and 
protection from diabetes.  However, antibody-mediated depletion of NK cells or CD8 T 
cells had no effect on the development of diabetes or survival of EMCV-D infection in 
WT mice (data not shown). We conclude that DC-mediated protection of β-cells from 
EMCV-D is independent of priming and/or activation of cytotoxic lymphocytes.  
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Discussion 
It is common knowledge that both RLR and TLR3 mediate responses to dsRNA and, 
possibly, RNA viruses. However, while RLR have been convincingly shown to be major 
players in innate responses to viruses in vivo, the literature is still contradictory as to the 
in vivo role of TLR3. Initial studies did not detect any role of TLR3 in anti-viral innate 
defense to EMCV (Kato, Takeuchi et al. 2006). However, more recent studies have 
revealed that TLR3 does in fact contribute to EMCV anti-viral responses (Hardarson, 
Baker et al. 2007). In this work we have demonstrated that both MDA5 and TLR3 
provide protection from EMCV-D infection, but their contributions are different in 
different tissues. In the heart, MDA5 plays the major role in determining resistance, in 
the endocrine pancreas TLR3 is more prominent, in the exocrine pancreas MDA5 and 
TLR3 are both important. Moreover, our bone marrow chimera studies demonstrated that 
MDA5 and TLR3 act predominantly in stromal and hematopoietic compartments, 
respectively. Thus, the differential roles of MDA5 and TLR3 are related to the distinct 
cellular distribution of these sensors, as well as the tissue tropism of the viruses.  
 
The type I IFN response to RNA viruses in vivo has been mainly attributed to RLRs. In 
this study we confirmed that MDA5 induces the bulk of type I IFN production in 
response to EMCV-D infection. However, using a sensitive bioassay for type I IFN, we 
found that TLR3-mediated type I IFN is small but rapid.  Thus, MDA5 and TLR3 induce 
type I IFN responses with different magnitude and kinetics. The reduced magnitude of 
type I IFN responses in the MDA5-/- mice explains the major survival defect, while 
TLR3-/- mice show a comparatively mild defect. On the other hand, the delayed kinetics 
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of the type I IFN response in TLR3-/- mice is responsible for the lack of viral control in 
endocrine pancreas and diabetes, highlighting the importance of this early response.  
Another study recently demonstrated that TLR2 is critical for early IFN production in 
response to several DNA viruses(Barbalat, Lau et al. 2009).  In that study, TLR2 
expression in inflammatory monocytes was particularly critical for the response.  In 
EMCV infection, dendritic cells were critical for early protection from diabetes. There 
are several known subsets of CD11c+ DCs which could play a role and it remains to be 
seen precisely which subset is responsible for this phenotype.   Because CD11c is 
expressed on a variety of cells of the myeloid lineage, we also cannot completely exclude 
a contribution from  monocytes and inflammatory macrophages.  Together, these results 
suggest that early TLR-mediated production of IFN by myeloid cells is an important 
component of the anti-viral response.   
 
Because of different cellular distributions as well as extent and timing of anti-viral 
responses, dsRNA sensors have different impact in distinct organs.  This was seen in our 
study contrasting the anti-viral response seen in the heart and the pancreas between the 
MDA5-/- and TLR3-/- animals.  This is a novel and important finding, which prompts the 
investigation of viral sensors in individual organs and cell types during in vivo infections. 
It is likely that anti-viral response in each organ relies on different dsRNA sensors and is 
highly dependent on the tropism of the virus.  Moreover, dsRNA and other TLR/RLR 
ligands are being increasingly used as adjuvants in vaccines with the idea that stimulation 
of the innate immune response will lead to increased and specific adaptive immune 
responses. However, this work has revealed that the timing and level of expression of the 
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sensors for these adjuvants varies during the antiviral response.  It is important that we 
understand the role of both the TLR and RLR systems in the immune response in 
different organs and cell types to best take advantage of this strategy. It may be possible 
to target these adjuvants to specific cells to maximize the desired immune response and 
minimize harmful effects of cytokine production. 
 
Although we did not observe the development of autoimmune diabetes after EMCV-D 
infection, our finding that MDA5-/- mice were resistant to EMCV-D-induced diabetes is 
intriguing.  Recent association studies have implicated the MDA5-encoding gene Ifih1 in 
susceptibility to human type I diabetes.  In those studies, rare human Ifih1 alleles which 
were shown to be defective for IFN production were seen to be protective, resulting in 
failure of individuals with these alleles to develop T1D(Nejentsev, Walker et al. 2009).  
Similarly, our results indicate that mice lacking MDA5 appear to be protected from 
diabetes after EMCV-D infection, even in the presence of detectable EMCV-D in the 
pancreatic islets.  It is possible that the diabetes phenotype in MDA5-/- mice is not seen as 
a result of the severe myocarditis the develops in these animals, however, the presence of 
hyperglycemia in IRF3-/- and IFNβ-/- animals, which have similar survival phenotypes 
and also develop myocarditis suggests that deficiency of MDA5 may be generally 
protective within pancreatic islets.  This may be due to the detrimental effects of IFN on 
β-cell survival or an IFN-independent effect of MDA5 on cell survival, which has 
recently been reported in studies of melanoma(Besch, Poeck et al. 2009; Tormo, 
Checinska et al. 2009). 
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Despite strong clinical correlation between viruses and diabetes as well as several 
experimental models in which virus infection results in diabetes, the underlying 
mechanism of how the human disease is initiated and whether viruses are directly 
involved remains unclear.  A recent report suggested that human diabetes can be initiated 
by different mechanisms(Dotta, Censini et al. 2007). This study examined pancreatic 
tissue of recent onset diabetic patients and reported two distinct histological patterns.  
Half of the patients were noted to have T cell infiltrates within the islets, similar to the 
autoimmune NOD mouse model. However, islets from other patients displayed 
coxsackievirus B4 antigen and contained NK and myeloid cell infiltrates, but no T cells.  
This suggests that type I diabetes may be initiated by either an autoimmune mechanism 
or by direct virus infection. Likewise, some studies of EMCV-D-induced diabetes have 
suggested that virus infection initiated an autoimmune T cell response, however, other 
studies have reported no T cell infiltrate in the islets.  Our results indicate that EMCV-
induced diabetes in TLR3-/- mice does not involve autoimmune T cells, instead diabetes 
results from direct viral infection of β-cells.  However, this study tested mice on the 
C57Bl/6 background, which are resistant to autoimmunity, and it is possible that studies 
of EMCV on a genetic background susceptible to autoimmunity would have a different 
outcome.  It is possible that polymorphisms in dsRNA sensors play a role in both 
autoimmune and virus-induced diabetes.  MDA5 polymorphisms have clearly been 
implicated in diabetes.  In addition, a recent study has implicated non-functional TLR3 
alleles with human myocarditis(Gorbea, Makar et al.), suggesting that inability to control 
virus infection can lead to human disease. In this context, polymorphisms leading to 
excessive IFN production by MDA5 may lead to autoimmune diabetes while non-
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functional alleles provide protection.  In contrast, nonfunctional TLR3 alleles may lead to 
increased susceptibility to viral infection and virus-induced diabetes.  Further 
investigation is needed to determine how these sensors function to both limit infection 
and trigger autoimmunity. 
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Experimental Procedures 
Mice and infections:  MDA5-/-(Gitlin, Barchet et al. 2006), TLR3-/-(Alexopoulou, Holt 
et al. 2001), DKO(McCartney, Vermi et al. 2009), CD11c-DTR(Jung, Unutmaz et al. 
2002), IRF3-/-(Sato, Suemori et al. 2000), and IFNβ-/- (Takaoka, Mitani et al. 2000)mice 
have been described previously.  All mice have been backcrossed to the C57Bl/6 
background.  Age-matched control mice were purchased from Jackson ImmunoResearch 
Laboratories, Inc.  All mice used in these experiments were male.  EMCV-D was 
obtained from Dr. John Corbett and was passaged in L929 cells.  Infections were done at 
1000 PFU per mouse by intraperitoneal injection. 
 
BM chimeras:  Recipient mice were γ irradiated with 1000 rad.  After an overnight rest, 
mice were reconstituted with 5 x 106 BM cells per mouse that had been harvested from 
the femurs and tibias of age-matched donors.  After 6 weeks, chimeras were used for 
infections. 
 
Virus titers: Organs from infected animals were frozen at -80°C immediately after 
harvest.  Subsequently, organs were suspended in 1ml DMEM and homogenized by bead 
beating with 1.0mm beads (BioSpec Products, Inc).  Organ homogenates were diluted 
1:10 in DMEM and tested for viral titers in a plaque assay.  L929 cells were seeded in 6 
well plates and infected with 10-fold dilutions of tissue homogenate in duplicate.  After 1 
hour incubation, the inoculum was removed and wells were overlaid with complete 
DMEM media containing 1.5% Seaplague agarose (Cambridge Biosciences).  After 48 
hours, a second overlay was added containing 1.5% SeaKem agarose (Cambridge 
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Biosciences) and 0.01% neutral red (Sigma)in complete DMEM media.  After 8 hours, 
plagues were then visualized. 
 
Blood/Serum measurements:  Blood was taken at various time-points after infection 
and centrifuged in serum separator tubes (Becton, Dickinson, and Co.) to isolate serum, 
which was kept at -80 until use.  Serum levels of troponin (Life Diagnostics, Inc) were 
determined by ELISA.  Blood glucose was measured by Ascencia Elite glucometer 
(Fisher) and care was taken to measure glucose levels at a consistent time of the day to 
minimize variation.  Serum levels of inflammatory cytokines were measured by Bioplex 
assay using the mouse-23plex kit (Bio-rad) on a Luminex machine.  
  
IFN bioassay:  IFN levels in the serum were determined by bioassay (Newby, Pekosz J 
Virol 2007).  Briefly, L929 cells were incubated for 24 hours with standards or samples, 
then infected for 10 hours with VSV-GFP.  Cells were fixed and the percent of GFP+  
cells were used to calculate IFN levels in the linear range of the standard curve.  This 
method was found to give similar results to IFNα ELISA (PBL), but was more sensitive 
for low IFN values. 
 
Liposome preparation and application:  Multilamellar liposomes containing clodronic 
acid disodium salt (Cl2MDP) (Sigma) in PBS or control liposomes without clodronate 
were prepared as described by van Rooijen(Van Rooijen 1989; Calderon, Suri et al. 
2006).  Briefly, 86mg of phosphatidyl choline (Sigma) and 8 mg of cholesterol (Sigma) 
were dissolved in 10 ml of chloroform and dried in an evaporator to form a lipid film.  
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The lipid was dispersed in 10 ml of PBS for control liposomes or 10 ml of Cl2MDP 
solution (2.5g into 10ml DI water, adjusted to pH 7.3) for clodronate liposomes.  The 
preparations were kept for 2 hours at room temperature, sonicated for 3 minutes, and 
incubated overnight at 4ºC. Liposomes were then purified and washed by centrifugation 
and resuspended in 4 ml of sterile PBS.  A volume of 0.1 ml of liposome suspension for 
every 10 g of body weight was injected i.v. for 5 consecutive days starting 48 hours 
before EMCV infection. 
 
Histology:  Organs were harvested at indicated time-points after infection and tissue 
sections prepared by either formalin-fixation paraffin-embedding or frozen in OCT 
reagent.  For EMCVpol, iba-2, activate caspase-3, synaptophysin, and H&E staining, 
sections were deparaffinized, rehydrated, and stained with primary antibody at 1:1000 
and then secondary ab at 1:2000.  For TLR3 staining, frozen sections were stained with 
primary antibody at 1:500 and secondary antibody at 1:2000.   
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Figure Legends 
Figure 3.1: Both MDA5 and TLR3 protect from EMCV-D infection.  
WT, MDA5-/-, TLR3-/-, and DKO mice were infected with 1000 PFU EMCV-D i.p. and 
monitored for survival (n=20).  WT mice survived infection, MDA5-/- mice died at 
average day 5, TLR3-/- died at average day 20, and DKO mice died at average day 2. 
 
Figure 3.2: MDA5 is critical for protection in the heart. 
WT, MDA5-/-, TLR3-/-, and DKO mice were infected with 1000 PFU EMCV-D i.p.  
Serum and heart tissue were harvested at days 2, 4, and 7 from surviving mice and were 
evaluated for troponin by ELISA (n>5) (A) and virus titer by plaque assay (n>6 for each 
time point) (B). Statistical significance was calculated by two-tailed student’s t-test or 
Mann-Whitney test  for non-Gaussian data and is indicated by *= p<0.05, **= p<0.01, 
***= p<0.001. 
 
Figure 3.3: Both MDA5 and TLR3 control infection in the pancreas. 
WT and KO mice were infected with EMCV-D as above. Serum samples were evaluated 
for blood glucose (n>8) (A) or amylase and lipase (n>4) (B) at the indicated times post-
infection. Pancreas was harvested at the indicated times and viral titers were determined 
by plaque assay (C) (n>6). Statistical significance was calculated by two-tailed student’s 
t-test and is indicated by *= p<0.05, **= p<0.01, ***= p<0.001. 
 
Figure 3.4: Differential roles of MDA5 and TLR3 in the pancreas. 
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Pancreas tissue samples from WT or knockout mice were harvested at day 2 or 4 as 
indicated, fixed in formalin, and paraffin embedded.  Tissue sections were stained using 
anti-EMCVpol (A) or anti-iba-2 (B) by immunohistochemistry (n>3). Alternatively, 
sections were stained for anti-iba-2 (brown) and co-stained with synaptophysin (blue) (C-
a); anti-EMCVpol (brown) and synaptophysis (red) (C-b); anti-EMCVpol (brown) and 
anti-iba-2 (red) (C-c); or active caspase-3 (brown) and synaptophysin (blue) (C-d). 
 
Figure 3.5: MDA5 is critical in stroma, TLR3 in hematopoietic cells for control of 
EMCV infection. 
Bone marrow chimeras were developed between WT and MDA5-/- and WT and TLR3-/- 
animals.  Chimeras were infected with 1000PFU EMCV-D and evaluated for survival 
(n>10) (A) and blood glucose (n>10) (B). Statistical significance was calculated by two-
tailed student’s t-test and is indicated by *= p<0.05, **= p<0.01, ***= p<0.001. 
 
Figure 3.6: MDA5 and TLR3 control kinetically distinct IFN responses. 
Serum samples from WT, MDA5-/-, TLR3-/-, and DKO mice were harvested at various 
time-points after EMCV-D infection and evaluated for type I IFN production by bioassay 
(n>5 per time point) (A).  IRF3-/- and IFNb-/- mice were infected with EMCV-D and 
monitored for survival  (n=6) (B) and blood glucose (C).  IRF3-/- and IFNb-/- chimeras 
were infected with EMCV-D and monitored for survival (n=6) (D) and blood glucose 
(n=6) (E). Statistical significance was calculated by two-tailed student’s t-test and is 
indicated by *= p<0.05, **= p<0.01, ***= p<0.001. 
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Figure 3.7: CD11c+ cells required for protection from EMCV-D-diabetes. 
WT mice were treated with clodronate or PBS-containing liposomes and monitored for 
survival (n=8) (A) and blood glucose (n=8) (B) after EMCV-D infection.  CD11c-DTR 
mice were treated with PBS or DT then monitored for survival (n=6) (C) and blood 
glucose (n=6) (D) after EMCV-D infection. To visualize TLR3+ cell infiltrates in the 
islets, tissue sections were made from formalin-fixed paraffin-embedded WT pancreas 12 
hours after EMCV infection.  These sections were stained with anti-TLR3 (brown) and 
synaptophysin (blue) (E).  Statistical significance was calculated by two-tailed student’s 
t-test and is indicated by *= p<0.05. 
 
Supplementary Figure Legends 
Supplementary figure 3.1.  Extensive viral replication and pathology in MDA5-/- 
hearts. 
Heart tissue samples from WT or knockout mice were harvested at day 2, 4, or 7 as 
indicated, fixed in formalin, and paraffin embedded.  Tissue sections were stained by 
H&E and evaluated for pathology (A) or stained for EMCVpol by immunohistochemistry 
(B). 
 
Supplementary figure 3.2.  Pathological damage of EMCV-D infection in the 
pancreas. 
Pancreas tissue samples from WT or knockout mice were harvested at day 2, 4, or 7 as 
indicated, fixed in formalin, and paraffin embedded.  Tissue sections were stained by 
H&E and evaluated for pathology 
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Abstract 
The double stranded (ds) RNA analogue poly(I:C) is a promising adjuvant for cancer 
vaccines because it activates both dendritic cells (DC) and natural killer (NK) cells, 
concurrently promoting adaptive and innate anti-cancer responses. Poly(I:C) acts through 
two dsRNA sensors, Toll-like receptor 3 (TLR3) and melanoma differentiation-
associated protein-5 (MDA5). Here we investigated the relative contributions of MDA5 
and TLR3 to poly(I:C)-mediated NK cell activation using MDA5-/-, TLR3-/- and MDA5-/-
TLR3-/- mice. MDA5 was crucial for NK cell activation, whereas TLR3 had a minor 
impact most evident in the absence of MDA5.  MDA5 and TLR3 activated NK cells 
indirectly through accessory cells and induced distinct stimulatory cytokines, IFN-α and 
IL-12 respectively. To identify the relevant accessory cells in vivo, we generated bone 
marrow chimeras between either wild type and MDA5-/- or wild type and TLR3-/- mice.  
Interestingly, multiple accessory cells were implicated, with MDA5 acting primarily in 
stromal cells and TLR3 predominantly in hematopoietic cells. Futhermore, poly(I:C)-
mediated NK cell activation was not notably impaired in mice lacking CD8α DCs, 
providing further evidence that poly(I:C) acts through diverse accessory cells rather than 
solely through DC. These results demonstrate distinct, yet complementary roles for 
MDA5 and TLR3 in poly(I:C)-mediated NK cell activation.  
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Introduction 
Microbial components play a major role in activating innate and adaptive immune 
responses by triggering pattern recognition receptors (Ishii et al., 2008). Poly(I:C) is an 
analog of viral double-stranded (ds) RNA that activates various immune cell types 
through two major dsRNA sensors, melanoma differentiation-associated protein-5 
(MDA5) and Toll-like receptor (TLR) 3. MDA5 is a cytosolic sensor, which detects 
poly(I:C) that penetrates into the cytosol through yet undefined mechanisms (Ishii et al., 
2008). TLR3 is located in intracellular endosomes and detects poly(I:C) that has been 
internalized by endocytosis (Matsumoto and Seya, 2008). Upon poly(I:C) detection, 
MDA5 transmits signals through the adaptor IPS1, while TLR3 signals through the 
adaptor TRIF (also known as TICAM1). Both these adaptors initiate downstream 
signaling pathways that lead to activation of a similar array of transcription factors, 
including IRF3, IRF7, IRF1 and NF-κB. These factors induce the expression of genes 
encoding type I interferons (IFN), i.e. IFN-α and IFN-β, pro-inflammatory cytokines and 
various molecules involved in antigen presentation (Kawai and Akira, 2008). 
 
Poly(I:C) induces the maturation of dendritic cells (DC), boosting their ability to prime 
and expand antigen-specific T cell responses  (Kumar et al., 2008; Longhi et al., 2009; 
Trumpfheller et al., 2008). Because of this DC stimulatory activity, poly(I:C) is a 
promising adjuvant for vaccines, particularly for cancer vaccines that must overcome 
both tolerance to tumor-associated self-antigens and the immunosuppressive influence of 
the tumor microenvironment (Steinman and Banchereau, 2007). Poly(I:C) is also 
extensively used to activate mouse NK cells in vivo. The NK cell stimulatory activity of 
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poly(I:C) is potentially important for anti-cancer vaccines as it may contribute to tumor 
eradication by inducing NK cell-mediated lysis of tumor cells. In humans, the NK cell 
stimulatory activity of poly(I:C) has been chiefly attributed to its ability to trigger TLR3 
expressed in cultured NK cells (Hart et al., 2005; Lauzon et al., 2006; Schmidt et al., 
2004; Sivori et al., 2004). Whether poly(I:C) also activates human NK cells through DC 
or other accessory cells has not been investigated. In mice, poly(I:C) is thought to 
activate NK cells primarily through DC. An initial study showed that poly(I:C) stimulates 
TLR3 in DC, which consequently acquire the ability to activate NK cells (Akazawa et al., 
2007). A very recent study showed that poly(I:C) triggers both the TRIF and IPS-1 
signaling pathways in CD8α DCs, which in turn activate NK cells in vitro (Miyake et al., 
2009). These results suggest that TLR3 and MDA5 may stimulate murine NK cells 
indirectly through activation of DCs, particularly CD8α DCs.  
 
In this report we investigated the relative contributions of MDA5 and TLR3 in poly(I:C)-
mediated activation of NK cells using MDA5-/-, TLR3-/- and MDA5/TLR3-/- mice. We 
found that MDA5 has a predominant role in NK cell activation, whereas the contribution 
of TLR3 is secondary and is most evident in the absence of MDA5. Both MDA5 and 
TLR3 activated NK cell indirectly through accessory cells, but induced different NK cell 
stimulatory cytokines, as MDA5 was essential for IFN-α and IFN-β whereas TLR3 was 
required for interleukin (IL)-12 and, in part, for IFN-β. By generating bone marrow 
chimeras between wild type (WT) and dsRNA sensor-deficient mice, we found that 
MDA5 promotes NK cell activation mainly through stromal accessory cells, whereas 
TLR3 acts predominantly through bone marrow-derived accessory cells. To determine 
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whether the hematopoietic accessory cells that activate NK cells are, indeed, CD8α DC, 
we examined mice deficient for the basic leucine zipper transcription factor ATF-like 3 
(BATF3), which have a selective developmental defect in CD8α DC (Hildner et al., 
2008). We found that poly(I:C)-mediated stimulation of NK cells was minimally affected 
in these mice, indicating that poly(I:C) acts through multiple accessory cells, rather than 
solely through CD8α DC. We conclude that MDA5 and TLR3 mediate substantially 
distinct and yet complementary functions during poly-I:C-mediated activation of NK 
cells. 
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Results and discussion 
MDA5 has a predominant role in NK cell response to poly(I:C) in vivo. 
To investigate the relative contributions of MDA5 and TLR3 in poly(I:C)-mediated 
activation of NK cells, we injected WT, MDA5-/-, TLR3-/-, and MDA5/TLR3-/- (double 
knockout, DKO) mice with poly(I:C); after 24 hrs we isolated spleen NK cells and 
measured cytotoxicity ex vivo.  NK cells from untreated WT and sensor-deficient mice 
were unable to kill targets, while NK cells from poly(I:C)-treated WT mice killed up to 
50% of targets (Figure 1A).  NK cells from MDA5-/- mice treated with poly(I:C) had a 
significant defect in cytotoxicity as only 20% of target cells were killed at maximum 
effector:target ratios.  NK cells from TLR3-/- mice treated with poly(I:C) had a modest, 
but not significant cytotoxicity defect. However, NK cells from DKO mice were unable 
to lyse targets after poly(I:C) stimulation. These results suggest that MDA5 can largely 
compensate for lack of TLR3, and that TLR3 contribution to NK activation is evident 
only in the absence of MDA5. 
 
Another measure of NK cell activation is CD69 upregulation.  CD69 is a cell surface 
molecule induced by IFN-α/β that promotes lymphocyte retention in lymphoid organs 
(Shiow et al., 2006). Following injection of poly(I:C), CD69 upregulation was partially 
impaired in NK cells from MDA5-/- mice in comparison to those from WT mice and 
completely abrogated in NK cells from DKO mice (Figure 1B).  There was no decrease 
in CD69 expression in the TLR3-/- mice, further implying that the effect of poly(I:C) is 
predominantly mediated by MDA5.  To determine the contributions of MDA5 and TLR3 
to NK cell production of IFN-γ in response to poly(I:C), we isolated splenocytes 3 hrs 
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and 4 hrs after injecting WT and dsRNA sensor-deficient mice with poly(I:C), and 
determined the intracellular content of IFN-γ in NK cells. NK cells isolated from both 
MDA5-/- and TLR3-/- mice 3 hours after poly(I:C) injection produced less IFN-γ than WT 
NK cells (Figure 1C). However, by 4 hours following poly(I:C) injection, TLR3-/- and 
WT NK cells generated similar amounts IFN-γ, whereas MDA5-/- NK cells still produced 
less IFN-γ than either the TLR3-/- or WT NK cells.  DKO NK cells did not produce IFN-
γ at any time point assessed following poly(I:C) stimulation. Altogether, these results 
indicate that MDA5 plays a more predominant role than TLR3 in stimulating NK 
cytotoxicity, CD69 upregulation and IFN-γ production. 
 
MDA5 activates NK cells through an NK cell-extrinsic pathway 
Since MDA5 is ubiquitously expressed, poly(I:C) could directly activate mouse NK cells 
through MDA5. However, MDA5 is also expressed in DCs, which play a crucial role in 
activating NK cells (Andoniou et al., 2005; Andrews et al., 2003; Ferlazzo et al., 2002; 
Fernandez et al., 1999; Gerosa et al., 2002; Lucas et al., 2007; Mortier et al., 2008). Thus, 
poly(I:C) may activate mouse NK cells through DC or other accessory cells expressing 
MDA5. To test whether MDA5-mediated activation of mouse NK cells occurs in an NK-
intrinsic or -extrinsic manner, we co-cultured combinations of bone marrow DCs 
(BMDCs) and NK cells from WT or dsRNA sensor-deficient mice and measured 
cytotoxicity, CD69 upregulation and IFN-γ production in response to poly(I:C).  
Remarkably, the defect seen in NK cell activation in the MDA5-/- mice in vivo was 
entirely recapitulated in the co-cultures of WT NK cells with MDA5-/- BMDCs.  MDA5-/- 
BMDCs stimulated with poly(I:C) promoted NK cytotoxicity, CD69 upregulation and 
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IFN-γ secretion less effectively than did poly(I:C)-activated WT BMDCs,  (Figure 2A-
C).  Following exposure to poly(I:C), DKO BMDCs were almost entirely incapable of 
inducing NK activation. TLR3-/- BMDCs pulsed with poly(I:C) induced less IFN-γ 
production in NK cells than did similarly treated WT BMDCs, whereas NK cell 
cytotoxicity and CD69 expression were slightly augmented. No significant differences in 
NK cytotoxicity, CD69 expression and IFN-γ production were detected when NK cells 
from WT or DKO mice were co-cultured with poly(I:C)-activated WT BMDCs (Figure 
2D-F). Consistent with this result, purified NK cells exhibited only modest or no increase 
in CD69 expression and IFNγ secretion when directly stimulated with pIC even when 
pretreated with IFNα and/or IL-12 to induce MDA5 and TLR3 (Supplementary Figure 
1).  We conclude that poly(I:C)-induced NK activation through MDA5 and TLR3 occurs 
extrinsic to the murine NK cell itself. Moreover, while MDA5 deficiency in BMDC 
severely impaired cytotoxicity and CD69 expression, TLR3 deficiency had minor impact 
on these functions. In fact, TLR3 deficiency caused a slight increase of cytotoxicity and 
CD69 expression. These in vitro results further corroborate the concept that MDA5 plays 
a predominant role in murine NK cell activation, while the contribution of TLR3 is 
limited but quite evident in the complete abrogation of NK activation observed in the 
DKO mice and cells. 
 
MDA5 and TLR3 disparately promote the secretion of cytokines that stimulate NK 
cells  
A variety of cytokines have been shown to activate NK cells.  IFN-α/β augments NK cell 
lytic capacity and expression of CD69 (Gerosa et al., 2002; Gerosa et al., 2005; Swann et 
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al., 2007); IFN-α/β, IL-12 and IL-18 stimulate NK cell production of IFN-γ (Andoniou et 
al., 2005; Biron et al., 1999; Chaix et al., 2008; Ferlazzo and Munz, 2004; Nguyen et al., 
2002; Trinchieri, 1995); IL-15 and IL-2 promote NK cell survival, proliferation and 
effector functions (Granucci et al., 2004; Koka et al., 2004; Lucas et al., 2007; Mortier et 
al., 2008; Waldmann and Tagaya, 1999). Since stimulation of both MDA5 and TLR3 
with poly(I:C) leads to the production of IFN-α/β as well as inflammatory cytokines in 
DC and other cells (Kawai and Akira, 2008), we predicted that the defect in NK 
activation in vivo would be associated with a defect in cytokine production in the absence 
of these dsRNA sensors. We found that serum IFN-α was completely abolished in the 
MDA5-/- and DKO mice 24 hours after poly(I:C) stimulation (Figure 3A). In contrast, 
there was no defect in serum IFN-α in TLR3-/- mice compared to WT mice, consistent 
with previous studies (Kato et al., 2006; Kumar et al., 2008; Miyake et al., 2009). MDA5-
/- mice had WT levels of IL-12p40 in the serum, whereas serum IL-12p40 was completely 
abolished in TLR3-/- and DKO serum 6 hours after poly(I:C) stimulation (Figure 3B). 
Other cytokines potentially relevant for NK cell activation, such as IFN-β, IL-18, IL-1β, 
IL-15 or IL-12p70 were undetectable in the serum of all mice after poly(I:C) stimulation.  
 
Similar to our findings in the serum, we found that poly(I:C)-stimulated MDA5-/- and 
DKO BMDCs secreted less IFN-α than did WT BMDC (Figure 3C). TLR3-deficiency 
did not diminish but, in fact, slightly augmented the IFN-α response. MDA5-/- BMDC 
also failed to produce adequate amounts of IFN-β, although a very minor IFN-β response 
was detectable early after poly(I:C) stimulation (Figure 3D). The IFN-β response was 
partially reduced in TLR3-/- BMDCs and completely abolished in DKO BMDCs. Thus, 
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MDA5 is essential for both IFN-α and IFN-β responses to poly(I:C), whereas TLR3 is 
dispensable for IFN-α, although it contributes to IFN-β production.  As opposed to type I 
IFNs, MDA5-/- BMDCs secreted WT levels of IL-12p40, whereas TLR3-/- BMDCs 
produced essentially no IL-12p40  (Figure 3E).   
 
We conclude that MDA5 and TLR3 induce cytokines in response to poly(I:C) in different 
ways. MDA-5 is required for the IFN-α and IFN-β response to poly(I:C), but not IL-
12p40. In contrast, TLR3 is required for IL-12p40 and, to a certain extent, IFN-β but is 
not essential for IFN-α production. Consistent with previous studies in vivo (Longhi et 
al., 2009), we found that poly(I:C)-induced NK cell activation in vitro was severely 
impaired in the presence of an antibody that blocks the receptor for type I IFN (IFNAR) 
(supplementary figure 2A, B). Moreover, co-cultures of NK cells and DC lacking IFNAR 
showed that NK cell activation requires IFN-α signaling in both NK cells and DC 
(supplementary figure 2C, D). Thus, type I IFNs are required for robust NK cell 
activation; because MDA5-/- mice secrete very little IFN-α and IFN-β in response to 
poly(I:C), the scarcity of these cytokines is probably responsible for the global defect in 
NK cell activation in MDA5-/- mice following stimulation with poly(I:C).  Although IL-
12 stimulates IFN-γ secretion (Trinchieri, 1995), the addition of an antibody neutralizing 
IL-12 to co-cultures of NK cells and DC had minimal impact on poly(I:C)-induced NK 
cell secretion of IFN-γ (supplementary figure 2A, B). Thus, the partial defect in IFN-γ 
secretion observed in TLR3-/- mice may be due to insufficient IFN-β, perhaps combined 
with the lack of IL-12 and/or other cytokines (Matikainen et al., 2001). Yet undefined 
TLR3-induced cell-cell interactions might also contribute to NK cell secretion of IFN-γ. 
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MDA5 and TLR3 function in different accessory cell populations 
Our data indicate that MDA5 and TLR3 have distinct quantitative and qualitative impacts 
on NK cell activation by poly(I:C). One potential explanation for this is differential 
expression of MDA5 and TLR3 in cell types that have distinct capacities to produce 
cytokines.  To address this possibility we investigated the expression of MDA5 and 
TLR3 in the spleen and liver before and after poly(I:C) stimulation by 
immunohistochemistry. In naïve mice, MDA5 was broadly expressed in the red pulp and 
the T-cell area of the spleen, and in the hepatocytes and interstitial cells of the liver 
(Figure 4A). In contrast, TLR3 expression was more limited, including DC of the white 
pulp, rare lymphoid cells in the marginal zone, red pulp macrophages as well as liver 
interstitial cells, likely corresponding to Kupffer cells and endothelial lining cells (Figure 
4B). Poly(I:C) stimulation induced a very strong increase in MDA5 expression in both 
spleen and liver, with the only notable exception in the splenic B-cell area (Figure 4A). 
Poly (I:C) stimulation also induced broader expression of TLR3 in the spleen, 
particularly in the B-cell area, and in the liver, including the hepatocytes (Figure 4B). 
These results suggested that MDA5 and TLR3 are constitutively expressed in partially 
distinct cellular compartments of the spleen and liver, with MDA5 being more broadly 
expressed than TLR3. Administration of poly(I:C) stimulates a stronger and broader 
expression of both sensors, consistent with previous reports showing that type I IFNs 
induce MDA5 (Ishii et al., 2008) and TLR3 expression (Matsumoto and Seya, 2008); 
even under these conditions, however, the distribution of MDA5 and TLR3 do not 
entirely overlap.  
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To test the importance of MDA5 and TLR3 in the stromal versus hematopoietic 
compartments, we created radiation chimeras between WT and MDA5-/- as well as WT 
and TLR3-/- mice.  Upon poly(I:C) stimulation, defective NK cell-mediated cytotoxicity 
and reduced serum levels of IFN-α were seen in MDA5-/- chimeras that had received WT 
bone marrow, while no cytotoxicity defect and minor impairment of systemic IFN-α 
were observed in WT chimeras that had been grafted with MDA5-/- bone marrow (Figure 
5A, B). Conversely, a slight decrease in cytotoxicity and marked reduction of systemic 
IL-12p40 was evident in WT chimeras that had received TLR3-/- bone marrow showed, 
while no obvious cytotoxicity or systemic IL-12p40 defects were observed in TLR3-/-
/WT chimeras that were grafted with WT bone marrow (Figure 5A, C).  These results 
indicate that MDA5 activates NK cells by acting predominantly in the radio-resistant 
stromal cell population, while TLR3 activates NK cells mainly through radio-sensitive 
hematopoietic accessory cells.   
 
Poly(I:C)-mediated NK cell activation in vivo occurs independently of CD8α DCs. 
Since TLR3 is highly expressed in CD8α DC (Edwards et al., 2003) and CD8α DC 
specialize in the secretion of IL-12 (Maldonado-Lopez et al., 1999), it seemed plausible 
that the hematopoietic accessory cells involved in TLR3-induced NK cell activation 
were, in fact, CD8α DC. This possibility was further supported by a recent study showing 
that poly(IC) triggers the TRIF and IPS1 signaling pathways in CD8α  DCs, inducing the 
secretion of IL-12 and type I IFNs that activate NK cells in vitro (Miyake et al., 2009). 
To directly test the contribution of CD8α  DC to poly(I:C)-mediated NK cell activation in 
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vivo, we analyzed Batf3-/- mice, which selectively lack the CD8α  DC population (Hildner 
et al., 2008).  Following injection of poly(I:C), NK cells isolated from Batf3-/- killed 
RMA-S cells only slightly less efficiently than WT NK cells (Figure 6A).  Upregulation 
of CD69, NK cell secretion of IFN-γ, serum IFN-α  and serum IL-12p40 were similar in 
Batf3-/- and WT mice (Figure 6B-E).  These results indicate that poly(I:C) triggers 
secretion of NK cell stimulatory cytokines through multiple accessory cells rather than 
solely through CD8α DC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 118 
Concluding remarks 
In this study we provide the first demonstration that MDA5 is essential for robust 
activation of murine NK cells in response to poly(I:C). While previously published 
studies have suggested that poly(I:C) activates NK cells primarily through TLR3, our 
data show that MDA5 is, in fact, more important than TLR3 for triggering all NK cell 
functions, including cytotoxicity, CD69 and IFN-γ production. TLR3 has a minor impact 
on NK cell activation and its role is most evident in DKO mice, where the lack of MDA5 
and TLR3 completely abrogates the NK cell response to poly(I:C). This result also 
excludes any contribution of other dsRNA sensors, such as RIG-I, to poly(I:C)-mediated 
NK cell activation.  
 
We demonstrated that MDA5- and TLR3-mediated NK cell activation is NK cell-
extrinsic. This conclusion is supported by in vitro experiments showing that lack of both 
MDA5 and TLR3 in NK cells has no impact on the ability of poly(I:C) to induce NK cell 
activation in the presence of WT DC, whereas deficiency of MDA5 and/or TLR3 in DC 
impairs activation of WT NK cells. Similar results were recently obtained by Miyake et 
al. (Miyake et al., 2009). Moreover, the extrinsic function of MDA5 was further 
supported by in vivo experiments, showing that poly(I:C)-mediated NK cell activation is 
normal in lethally irradiated WT mice reconstituted with MDA5-/- bone marrow cells, 
which generate MDA5-/- NK cells. Although MDA5 is ubiquitously induced by type I 
IFNs and therefore may be also expressed in NK cells, NK cells most likely lack efficient 
mechanisms for poly(I:C) uptake, thereby preventing a direct effect of poly(I:C) on NK 
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cells. It remains possible that the administration of poly(I:C) with liposomal reagents that 
facilitate cytosolic entry of poly(I:C) may induce some direct activation of NK cells. 
 
MDA5 and TLR3 contributed to poly(I:C)-induced NK cell activation by inducing 
different NK cell stimulatory cytokines. MDA5 promoted IFN-α and IFN-β secretion, 
whereas TLR3 was essential for IL-12p40 and, in part, for IFN-β production. Our in vitro 
data indicates that type I IFNs are crucial for poly(I:C)-induced NK cell activation. These 
data are consistent with the recent observation that NK cell secretion of IFN-γ in response 
to poly(I:C) is blocked by injection of an anti-IFNAR antibody in vivo (Longhi et al., 
2009). The crucial role of type I IFNs in poly(I:C)-mediated NK cell activation, together 
with the predominant function of MDA5 in inducing IFN-α and IFN-β secretion explain 
the major defect in NK cell activation in MDA5-/- mice. Although IL-12 is a known 
inducer of IFN-γ (Trinchieri, 1995), blockade of IL-12 did not affect poly (I:C)-induced 
secretion of IFN-γ by NK cells, at least in vitro.  Therefore, the transient defect in NK 
cell secretion of IFN-γ observed in TLR3-/- mice may be due to insufficient IFN-β, 
perhaps combined with a defect in IL-12 and/or other cytokines (Matikainen et al., 2001). 
While our data underscore the roles of MDA5 and TLR3 in inducing IFN-α and IL-12, 
MDA5 and TLR3 may also act by inducing cell surface molecules on accessory cells that 
activate NK cells through cell-cell interactions or local delivery of cytokines. This is the 
case for the α chain of the IL-15 receptor (IL-15Rα), which is induced by type I IFNs 
and allows accessory cells to trans-present IL-15 to NK cells (Koka et al., 2004; Lucas et 
al., 2007; Mortier et al., 2008). Accordingly, transcriptional analysis of WT, MDA5-/- and 
TLR3-/- BMDCs stimulated in vitro with poly (I:C) showed that both MDA5 and TLR3 
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are required for the induction of both IL-15Rα and its ligand IL-15 (supplemental figure 
3). MDA5 and TLR3 may induce other cell surface molecules on accessory cells 
involved in NK cell activation, either indirectly through type I IFN signaling, or directly 
through IPS1 and TRIF and their downstream transcription factors IRF1/3/7 and NF-κB.  
 
Our data indicates that the disparate impacts of MDA5 and TLR3 on poly(I:C)-induced 
secretion of  IFN-α, IFN-β and IL-12p40 and NK cell activation may be related, at least 
in part, to the distinct cellular distribution of MDA5 and TLR3. Bone marrow chimera 
experiments demonstrated that MDA5 mainly acts through stromal cells. The surfeit of 
these cells and their general ability to produce type I IFNs can explain why MDA5 
stimulation leads to a major release of IFN-α. MDA5 may have a more limited role in IL-
12 secretion because, although IFN-α induces IL-12p35 (Gautier et al., 2005; Hermann et 
al., 1998), it also modulates IL-12 production from DC and monocytes/macrophages 
(Nguyen et al., 2000).  In contrast, TLR3 has a more restricted distribution and acts 
mainly through hematopoietic cells. This may explain why TLR3 has a minor impact on 
systemic IFN-α and a more prominent effect on IL-12 production. Although CD8α DC 
express TLR3 (Edwards et al., 2003), specialize in the secretion of IL-12 (Maldonado-
Lopez et al., 1999), produce type I IFNs (Longhi et al., 2009) and strongly activate NK 
cells in vitro in response to poly(I:C) (Miyake et al., 2009), our analysis of BATF3-/- mice 
that lack CD8α DC demonstrates that poly(I:C)-mediated NK cell activation occurs even 
in the absence of these cells, indicating that TLR3 acts through a variety of hematopoietic 
accessory cells. Immunohistochemical analysis of TLR3 expression suggests that these 
cells may include various DC and macrophage subsets in the white and the red pulp of 
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the spleen as well as marginal zone B cells.  In conclusion, our studies elucidate the 
mechanisms by which poly(I:C) activates NK cells in vivo, demonstrating distinct, yet 
complementary roles for MDA5 and TLR3 in stimulating NK cell effector functions 
through a multiplicity of accessory cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 122 
Acknowledgements 
We would like to thank Cristina Rossini and Silvia Lonardi (University of Brescia) for 
excellent expertise in performing immunohistochemistry; David M. Segal (NIH) for anti-
TLR3 antibody; Richard Flavell (Yale University) for TLR3-/- mice; Kai Hildner for 
intitial generation of Batf3-/- mice; Tom Hannan for reviewing the manuscript; Aaron 
Rapaport for help in transcriptional profiling of BMDCs. The authors have no conflicting 
financial interests. This project was supported by JDRF grant #24-2007-420 to MC. SM 
is supported by NRSA Award Number F30HL096354 from the NHLBI. The opinions in 
this manuscript as those of the authors and do not reflect the positions of the JDRF or 
NHLBI. 
 123 
Materials and Methods 
Mice, cell lines, and antibodies.   MDA5-/-, TLR3-/-, and IFNAR-/- mice have been 
described previously (Alexopoulou et al., 2001; Trumpfheller et al., 2008).  DKO mice 
were made by intercrossing MDA5-/- and TLR3-/- mice.  These mice have been 
backcrossed to the C57Bl/6 background. Age- and sex- matched C57BL/6 control mice 
were purchased from the Jackson labs.  Batf3-/- (Hildner et al., 2008) and WT (Taconic) 
mice were on the 129SvEv background except for those used for IFN-γ staining, which 
were backcrossed 6 times onto the C57BL/6 background. All mouse protocols were 
approved by the Washington University Animal Care Committee. RMA-S cells were 
maintained in RPMI 1640 supplemented with 10% FCS, penicillin/streptomycin, and 
Glutamax. Blocking antibodies included anti-IFNAR (MAR1-5A3), anti-IL-12 (Tosh, 
kindly provided by Emil R. Unanue) and anti-human IFNγR (GIR-208) as isotype 
control. 
 
Bone marrow chimeras. Recipient mice were γ irradiated with 1000 rad.  After an 
overnight rest, mice were reconstituted with 5 x 106 bone marrow cells per mouse that 
had been harvested from the femurs and tibias of age- and sex- matched donors.  After 6 
weeks, chimeras were used for in vivo pIC stimulations. 
 
Cell preparations.  Single cell suspensions were prepared from spleens and depleted of 
erythrocytes by ammonium chloride lysis.  For NK purification, cell suspensions were 
incubated with anti-DX5 coated MACS beads (Miltenyi) and purified by autoMACS.  
Primary cells were cultured in complete media (RPMI 1640 (w/o) L-glutamine 
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supplemented with 10% FCS, Sodium Pyruvate, Kanamycin sulfate, Glutamax, and non-
essential amino acids). BMDCs were cultured in complete media with 2% GM-CSF for 7 
days and then used in assays with complete media. 
 
NK-DC co-cultures. For NK-DC cell co-culture experiments, 1x105 BMDCs were 
cultured with 5 x104 NK cells in the presence or absence of 25µg poly(I:C) (invivogen).  
In some experiments anti-IFNAR, anti-IL-12p70 or control antibody were added to the 
cultures before the addition of the poly(I:C).  In other experiments, purified NK cells 
alone were stimulated with 0, 25, or 100µg poly(I:C) in the presence of 200, 1000, or 
5000U IFNα (PBL); 1, 10, or 100ng/ml IL-12 (Peprotech); or 1ng/ml each IL-12 and IL-
18(Peprotech).  After 24 hours, supernatants were harvested for cytokine detection and 
NK cells were detached by washing with 1mM EDTA in PBS and analyzed by FACS.  
 
Cytotoxicity Assays.  To measure NK cytotoxicity ex vivo, splenocytes were prepared as 
described above 24 hours after injecting mice with 100µg poly(I:C) i.v. and mixed with 
1x105 Cr51-labeled RMA-S targets in decreasing E:T ratios. To measure NK cytotoxicity 
in NK-DC co-cultures, Cr51-labeled RMA-S targets were directly added to the NK-DC 
co-cultures. After 4 hours, supernatants were harvested and Cr51 release was measured in 
individual samples as well as maximum and spontaneous release samples. Specific lysis 
was calculated by (specific release) – (spontaneous release)/ (max release) – 
(spontaneous release).   
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FACS analysis.  Splenocytes, cultured NK cells and BMDC prepared as described above 
were treated with Fc block (HB-197) and stained with anti-CD3, anti-NK1.1, and anti-
CD69 (BD) for NK cells activation experiments or with anti-DX5 in place of NK1.1 for 
Batf3-/- mice. Samples were processed on a FACSCalibur and analyzed with CellQuest 
software (BD). 
 
Ex vivo IFN-γ  production.  Mice were injected with 100µg poly(I:C) i.v. After 3 or 4 
hours, splenocytes were prepared as described above and cultured with monensin for an 
additional 3 or 4 hours.  After incubation, cells were stained with anti-CD3 and anti-
NK1.1 or anti-DX5 (Batf3-/-) then fixed with PFA and permeabilized with saponin buffer 
and stained with anti-IFN-γ.  Samples were then analyzed by FACS as described above to 
detect percentage of IFN-γ-producing NK cells. 
 
Cytokine measurements. Serum samples were taken at 6 and 24 hours after injecting 
mice with 100µg poly(I:C); supernatants of NK-DC cultures were harvested at 0, 6, 12, 
and 24 hours after poly(I:C) stimulation. Type I IFNs and IL-12p40 were determined by 
ELISA (PBL and eBioscience, respectively); IFN-γ was assessed by CBA (BD). 
 
Statistics. Figures were plotted using Prism4 (GraphPad Software) indicating the mean 
and standard deviation. Statistical significance was determined primarily by student’s t 
test. ANOVA was used to determine significance for cytotoxicity assays.  Significance is 
indicated by * p<0.05, ** p<0.001, and *** p<0.0001. 
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Immunohistochemistry. Spleen and liver sections were obtained from frozen (for anti-
TLR3 staining) and formalin-fixed paraffin-embedded tissue (for anti-MDA5 staining). 
Primary antibodies included anti-MDA5 (rabbit polyclonal anti-mouse, AL180, Alexis, 
Plymouth Meeting, PA, USA); anti-TLR3 (rat anti-mouse 11F8.1B7, kindly provided by 
David M. Segal, Experimental Immunology Branch, NCI); anti-B220 (Caltag 
Laboratories) and anti-CD3 (rabbit monoclonal SP7, Thermo scientific). Anti-TLR3 and -
B220 were detected, after endogenous biotin blocking, using a rabbit anti-rat IgG (Mouse 
Absorbed; Vector Laboratories, Burlingame, CA, USA). For anti-MDA5 and -CD3 
stainings, sections were deparaffinized and subjected to antigen retrieval by incubating in 
a water bath at 98°C for 40 minutes. Primary antibodies were detected using Envision 
Rabbit (Dako, Glostrup). Reactions were revealed by DAB. 
 
RNA preparation and RT-PCR. BMDCs were stimulated with 25µg poly(I:C) for 6 or 
12 hours then RNA was harvested from the cells by RNeasy kit (invitrogen). cDNA was 
synthesized from RNA (Superscipt RT kit, invitrogen) and relative levels of IL-15 and 
IL-15Ra were determined by semi-quantitative PCR and normalized to GAPDH using the 
following primers: IL-15-sense 5'-GCAGAGTTGGACGAAGAC-3' ; IL-15-antisense 5'-
AGCACGAGATGGATGTATT-3' ; IL-15Rα-sense 5'-TCTCCCCACAGTTCCAAAAT-
3'; IL15Rα-antisense 5'-GGCACCCAGGCTCAGTAAAA-3'; GAPDH-sense 5'-
GAGCCAAAAGGGTCATCATC-3'; GAPDH-antisense 5'-
CCATCCACAGTCTTCTGGGT-3'. 
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Figure Legends 
Figure 4.1. Poly(I:C)-induced NK cell activation is primarily mediated by MDA5. 
WT, MDA5-/-, TLR3-/-, and DKO mice were injected with 100µg poly(I:C) i.v.  After 24 
hours, splenocytes were harvested and used as effector cells in a cytotoxicity assay with 
labeled RMA-S targets (experiment performed using 1 mouse for each genotype in 4 
independent trials) (A) or assayed for CD69 expression by FACS, gating on NK1.1+CD3- 
splenocytes (experiment performed using 2 mice for each genotype in 3 independent 
trials) (B). Alternatively, 3 or 4 hours after poly(I:C) injection, splenocytes were isolated, 
cultured with monensin for an additional 3 or 4 hours, and analyzed for intracellular 
content of IFNγ by FACS, gating on NK1.1+CD3- cells (experiment performed using 1 
mouse for each genotype in 3 independent trials) (C).  Statistical significance is indicated 
by * p<0.05, ** p<0.001, and *** p<0.0001. 
 
Figure 4.2.  MDA5 and TLR3 activate NK cells through NK cell-extrinsic 
mechanisms. BMDCs from WT, MDA5-/-, TLR3-/-, and DKO mice were cultured with 
purified NK cells from WT mice in the presence or absence of 25µg poly(I:C).  After 24 
hours NK1.1+CD3- cells were stained for CD69 expression (A) and IFNγ was measured 
from culture supernatants (B) (experiments performed using BMDCs from 1 mouse for 
each genotype and NK cells from 3 pooled mice in 4 independent trials).  Alternatively, 
Cr51-labeled RMAS targets were added to culture and cytotoxicity was measured (C) 
(experiments performed using BMDCs from 1 mouse from each genotype and NK cells 
from 3 pooled mice in 3 independent trials).  In reverse experiments, BMDCs from WT 
mice were cultured with purified NK cells from WT or DKO mice with or without 
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poly(I:C).  After 24 hours CD69 expression was determined by FACS (D) (experiments 
performed using BMDCs from 1 mouse and NK cells from 3 pooled mice of each 
genotype in 4 independent trials), IFNγ was measured in supernatants (E) (experiments 
performed using BMDCs from 1 mouse and NK cells from 3 pooled mice of each 
genotype in 4 independent trials), and cytotoxicity was measured against RMAS targets 
(F) (experiments performed using BMDCs from 1 mouse and NK cells from 3 pooled 
mice of each genotype in 3 independent trials). Statistical significance is indicated by * 
p<0.05, ** p<0.001, and *** p<0.0001. 
   
Figure 4.3.  MDA5 and TLR3 mediate distinct cytokine responses. 
WT, MDA5-/-, TLR3-/-, and DKO mice were injected with 100µg poly(I:C) i.v.  Serum 
was taken at 6 and 24 hours and assayed for IFN-α (experiment performed with serum 
from 5 mice of each genotype in 1 independent ELISA assay) (A) or IL-12p40 
(experiment performed with serum from 4 mice of each genotype in 1 independent 
ELISA assay) (B) by ELISA. BMDCs from WT, MDA5-/-, TLR3-/-, and DKO mice were 
stimulated with 25µg poly(I:C).  At various time-points after stimulation, supernatants 
were harvested and IFN-α (C), IFN-β (D), IL-12p40 (E) were measured by ELISA 
(experiments performed with supernatants from BMDCs from each genotype in 4 
independent experiments and evaluated by 2 independent ELISA assays). Statistical 
significance is indicated by * p<0.05, ** p<0.001, and *** p<0.0001. 
 
Figure 4.4. Expression patterns of MDA5 and TLR3 in spleen and liver. 
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Frozen tissue sections from spleen and liver of unstimulated MDA5-/- and WT mice and 
from poly(I:C)-injected WT mice were stained with anti-MDA5 (brown) and 
counterstained with Hematoxylin (blue) (A). Formalin-fixed sections from spleen and 
liver of unstimulated TLR3-/- and WT mice and poly(I:C)-injected WT mice were stained 
with anti-TLR3 (brown) and counterstained with Hematoxylin (blue) (B) (experiments 
performed using organs from 2 unstimulated and 4 pIC stimulated mice for each 
genotype with staining done at least in duplicate for each). WP, white pulp; RP, red pulp. 
Magnification = 200X, Scale bar = 100 microns. Expression of TLR3 in the B cell area of 
the spleen was confirmed by staining with anti-B220 and anti-TLR3 (data not shown). 
 
Figure 4.5. MDA5 and TLR3 act in different cellular compartments. 
Bone marrow chimeras consisting of WT>MDA5-/-, MDA5-/->WT, WT>TLR3-/-, and 
TLR3-/->WT mice were stimulated with 100µg poly(I:C) i.v.  After 24 hours splenocytes 
were harvested and used as effector cells in cytotoxicity assays against Cr51 labeled 
RMAS targets (experiments performed using 1 mouse for each chimera in 3 independent 
trials) (A). Additionally, serum was collected to measure systemic IFN-α (B) and IL-
12p40 (C) (experiments performed with serum from 4 mice of each chimera in 1 
independent ELISA assay). Statistical significance is indicated by * p<0.05, ** p<0.001, 
and *** p<0.0001. 
 
Figure 4.6. Poly (I:C)-induced NK cell activation is independent of CD8α DCs. 
WT and Batf3-/- mice were injected with 100µg poly(I:C) i.v.  After 24 hours, 
splenocytes were harvested and used as effector cells in a cytotoxicity assay with labeled 
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RMA-S targets (experiments performed using 1 mouse for each genotype in 3 
independent trials) (A) or assayed for CD69 expression by FACS, gating on DX5+CD3- 
splenocytes (experiments performed using 2 mice for each genotype in 2 independent 
trials) (B). Alternatively, 3 hours after poly(I:C) injection, splenocytes were isolated and 
cultured with monensin for 3 additional  hours, at which time DX5+CD3- cells were 
analyzed by FACS for intracellular IFN-γ content (experiments performed using 1 mouse 
for each genotype in 3 independent trials) (C). Serum samples from poly(I:C) injected 
mice were taken at 24 hours and IFN-α (D) and IL-12p40 (E) were measured by ELISA 
(experiments performed with serum from 4 mice of each chimera in 1 independent 
ELISA assay).  Statistical significance is indicated by * p<0.05, ** p<0.001, and *** 
p<0.0001. 
 
Supplementary Figure Legends 
Supplementary Figure 4.1.  Limited effect of poly(I:C) on purified NK cells. 
Purified NK cells from WT and DKO mice were cultured with increasing doses of pIC 
along with IFNα or IL-12 alone or in combination.  As a positive control, NK cells were 
cultured with the combination of IL-12 and IL-18.  After 24 hours, NK cells were 
analyzed by FACS for CD69 expression (A-C) or IFN-γ  was measured from culture 
supernatants by CBA (D-F) (experiments performed using pooled NK cells from 5 mice 
for each genotype in 3 independent trials). 
 
Supplementary Figure 4.2. Type I IFN is essential for poly(I:C)-induced NK cell 
activation through NK cell intrinsic and extrinsic mechanisms. 
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(A, B) WT BMDCs were cultured with purified NK cells from WT mice in the presence 
of poly(I:C) and anti-mouse IFNAR (MAR1), anti-mouse IL-12, or anti-human IFNGR 
(GIR) as control.  After 24 hours, NK cells were analyzed by FACS for CD69 expression 
(A) or IFN-γ was measured in the co-culture supernatants (B) (experiments performed 
using BMDCs from 1 mouse and NK cells from 3 pooled mice in 3 independent trials).  
(C, D) Different combinations of WT and IFNAR-/- BMDCs and NK cells were co-
cultured with poly(I:C).  After 24 hours, CD69 expression (C) and IFN-γ production (D) 
were determined (experiments performed using BMDCs from 1 mouse for each genotype 
and NK cells from 3 pooled mice in 3 independent trials). Statistical significance is 
indicated by * p<0.05, ** p<0.001, and *** p<0.0001. 
 
Supplementary Figure 4.3.  MDA5 and TLR3 are required for poly (I:C)-induced 
expression of IL-15Rα  and IL-15. 
BMDCs from WT, MDA5-/-, TLR3-/-, and DKO mice were stimulated with poly(IC) for 6 
or 12 hours.  RNA was harvested and levels of IL-15 and IL-15Rα were determined by 
semi-quantitative PCR normalized to GAPDH (experiments performed using BMDCs 
from 1 mouse for each genotype and in 4 independent trials). Statistical significance is 
indicated by * p<0.05, ** p<0.001, and *** p<0.0001. 
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Abstract 
 Organisms use a number of proteins to detect viral infection and activate the 
antiviral response.  The preceding chapters have provided evidence that two of these 
proteins, the dsRNA sensors MDA5 and TLR3, have distinct functional roles in 
activation of the innate immune system and control of viral infection.  It is likely that the 
role of these sensors, and other sensors of the innate immune system, are dependent on 
several factors including viral tropism, cell and tissue specificity of PRRs, and 
downstream signaling components.  The combinations of these factors that occur during a 
given viral infection are critical for successful control of that infection and determination 
of the disease pathology.  This chapter addresses how the results in the previous chapters 
contribute to our understanding of how the RLR and TLR pathways work together to 
coordinate control of infection.  It also discusses potential mechanisms by which these 
pathways may contribute to human disease and how we can apply this knowledge to 
develop new therapeutic targets. 
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Understanding the diversity between viral sensors 
 In this work we tested whether viral sensors of the TLR and RLR families serve 
redundant or non-redundant functions. It has previously been appreciated that one way by 
which viral sensors can be seen to have differential effects is by the recognition of 
different ligands and thus different viruses, such as for Rig-I and MDA5.  However, 
several recent studies have demonstrated that both Rig-I and MDA5 function in a variety 
of viral infections, suggesting that different sensors may also recognize different 
components of the same virus, ensuring that multiple pathways are activated.  
Additionally, different downstream signaling components could ensure that PRRs 
activate the production of distinct cytokines.  Finally, the differential expression of viral 
sensors among tissues and cells types could contribute to their distinct roles in viral 
infection. Results obtained in chapters 2, 3, and 4 help to highlight the importance of 
these factors in the antiviral response. 
 
PRR signaling results in distinct cytokine responses 
 Both RLRs and TLRs are able to initiate IFN and inflammatory cytokine 
pathways in vitro.  More recent studies, however, have revealed differential signaling by 
RLRs and TLRs in individual cell types.  One study found that influenza infection in 
bronchial epithelial cells led to TLR3-dependent inflammatory cytokine induction and 
Rig-I- dependent IFN response(1).  Another recent study has demonstrated that human 
keratinocytes contain functional TLR, RLR, and PKR signaling pathways and with the 
use of siRNA and small molecule inhibitors they were able to show that TLR3 provides 
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the main stimulus for NF-kB signaling, while RLRs are the primary initiators of IRF3 
and IFN signaling in this cell type (2).  
 This work has also demonstrated that there is some specialization in cytokine 
production that is dependent on whether the signal is transduced by MDA5 or TLR3.  In 
chapter 4, in response to pIC, MDA5 was found to be critical for robust type I IFN 
production, while TLR3 was necessary for IL-12 production both in vivo and in vitro, 
supporting previous findings.  However, we also determined that there are important 
kinetic differences in MDA5 and TLR3 cytokine production.  Both in response to pIC in 
vitro and viral infection in vivo, TLR3 was found to function at early time points for type 
I IFN production.  In contrast, MDA5 was shown to be important for robust IFN 
production at late time points.  There are several possibilities for why MDA5 and TLR3 
are important for IFN production at different time points.  The first is cellular location.  
TLR3 is located in the endosomal compartment, while MDA5 is cytoplasmic.  To detect 
extracellular components, cells perform phagocytosis, which brings external contents into 
endosomal compartments.  This would allow initial contact with TLR3, with subsequent 
internalization events from the endosomal to the cytoplasmic compartment being 
necessary for contact with MDA5.  Second, while TLR3 is constitutively expressed on 
several cell types, MDA5 is an IFN-induced gene, and requires IFN production to be 
upregulated.  Therefore, early IFN production by TLR3 may serve to upregulate MDA5, 
allowing for robust IFN production if the viral pathogen remains present, while 
preventing needless systemic IFN responses if the TLR3 response is necessary to control 
infection.  In vivo another possibility for kinetic differences in MDA5 and TLR3 IFN 
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production is distribution in different cell types, which will be discussed in the next 
section.   
 The stimulation of different signaling pathways by TLRs and RLRs could have 
important implications.  Type I IFN and inflammatory cytokines promote distinct 
immune responses.  While IFN is known to activate a variety of immune cells, it also 
promotes intracellular antiviral responses.  In contrast, inflammatory cytokines typically 
act to promote inflammation and the recruitment of immune cells without specific 
antiviral activities.  If we are able to distinguish which receptor is preferentially 
responsible for the production of each cytokine, then we may be able to target activating 
ligands to the endosomal or cytoplasmic compartments to activate MDA5 or TLR3 
specifically to induce a particular cytokine response.  It may also be possible to take 
advantage of the kinetic difference in MDA5 and TLR3 signaling to initially target TLR3 
in order to initiate a robust early IFN response, rather than targeting cells which have yet 
to express MDA5.   These techniques could be a tremendous advantage to the fields of 
vaccine development as well as infectious diseases and tumor immunology since antiviral 
sensors and their ability to induce cytokines are potential targets for therapy and 
prevention.  However, more work is needed to understand how individual and 
combinations of cytokines act to control immune activation if we are to take advantage of 
this knowledge. 
 
Differential distribution of PRRs 
 The distribution of viral sensors in different cell and tissue types may be another 
mechanism to differentiate their actions.  This has been previously described in 
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comparison between conventional dendritic cells (cDC) and plasmacytoid DCs (pDC). 
cDCs are specialized for pathogen detection and antigen presentation, while pDC 
specialize in the secretion of type I IFNs in response to viruses (3, 4). In humans cDCs 
express TLR1, 2, 3, 4, 5, 6 and 8, while pDCs preferentially express TLR7 and 9.  CDCs 
are capable of expressing high levels of RIG-I and MDA5, while pDCs also express these 
cytoplasmic sensors, but, paradoxically, the sensors do not appear to function (5) unless 
the pDCs themselves are infected(6).  Although both cell types express different sensors, 
they both respond to viruses and initiate an antiviral response. 
 Our data suggests that a similar mechanism exists between hematopoietic and 
stromal tissues.  In the response to both dsRNA and viral infection, we found that TLR3 
functions in hematopoietic cells, while MDA5 functions in stromal tissues.  Expression 
patterns of the two sensors demonstrate that while MDA5 can be expressed on all cell 
types after IFN stimulation, TLR3 is expressed on a more narrow range of cells primarily, 
but not limited to, hematopoietic myeloid cells.  It is likely that these different expression 
patterns in vivo explain the functional differences between the two sensors.  The presence 
of TLR3 on hematopoietic cells suggests that these cells are important for initial 
detection of viral infection. In this context TLR3 may be necessary to recognize dsRNA 
from other cells that have been infected instead of by the infected cell itself.  This is 
supported by viral replication experiments in which MDA5, but not TLR3, is necessary 
to limit viral replication of both MNV-1 (chapter 2) and EMCV (data not shown) in 
infected dendritic cells in vitro.  Production of early IFN by TLR3 may then lead to 
induction of MDA5 on surrounding cells.  This could lead to additional IFN production 
as well as IFN-independent effects of MDA5, such as apoptosis, in infected cells that are 
 151 
necessary to control infection.  However, this paradigm may not occur for all tissues, and 
it is possible that different organs could have different expression patterns of PRRs.   
 The differential distribution of viral sensors may also be necessary to combat a 
variety of different viral tropisms.  Even within the picrona- and calici- virus families, 
that is a broad distribution of viruses that infect different tissues as reviewed in chapter 1.  
This likely explains the differential importance of MDA5 and TLR3 in control of their 
infection.  Infection of MDA5/TLR3 DKO mice with EMCV results in similar 
susceptibility compared to mice lacking IFNAR, suggesting that these sensors are mostly 
sufficient to control this infection. However, infection of MDA5-/- or DKO (data not 
shown) mice with MNV-1 or CVB(7) results in a much less severe phenotype than 
IFNAR-/- animals, suggesting that additional antiviral sensors are necessary to for 
complete control of these infections.  This could be related to the production of distinct 
viral nucleic acid intermediates, but also could represent infection within different cell 
types that are protected by different sensors.  Thus, studying the expression patterns of 
TLR and RLR family members in different organs and in response to different infection 
may be necessary to understand their functional roles. 
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Implications for human diseases 
T1DM 
 Viruses have long been implicated in T1DM.  However, a direct causal role in 
initiation of the disease has never been proven.  Recent studies implicating MDA5, a 
dsRNA sensor involved in detection of viral infection provided hope that such a 
mechanism may be discovered.  In chapter 3 we tested the importance of MDA5 in 
prevention of virus-induced diabetes.  Interestingly, mice lacking MDA5 did not develop 
diabetes after EMCV-D infection, but rather developed myocarditis.  However, mice 
lacking TLR3 were highly susceptible to diabetes after EMCV infection, although TLR3 
has not been implicated in diabetes in mice or humans.  Is it possible to make sense of 
this paradox?  Results from human studies suggest a potential explanation.  Work by 
Dotta and others revealed two distinct histological patterns in recent onset diabetic 
patients, one characterized by T cell infiltrate and the other by myeloid cell infiltrate.  In 
addition, viral antigens were detected in samples containing the myeloid infiltrate, but not 
the T cell infiltrate, suggesting two potential mechanisms of T1DM- autoimmune and 
viral.  In this model MDA5 is implicated in autoimmune diabetes, while TLR3 may play 
a role in diabetes initiated by viral infection. 
 Several studies have implicated MDA5 in autoimmune diabetes.  Work by the 
Todd group identified genetic polymorphisms that both increase and decrease 
susceptibility to T1DM(8, 9).  The mechanism by which these polymorphisms affect 
T1DM susceptibility remain unclear, however, polymorphisms that result in defective 
MDA5 IFN production appear to mediate resistance to T1DM.  This is interesting 
because of the known role for type I IFN in autoimmune diseases, and the myriad of 
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effects type I IFN has on both β cells and the immune response in the islets.  In contrast, 
our results suggest that MDA5 does not play a role in virus-induced diabetes.  This was 
somewhat surprising because MDA5 is known to limit viral replication.  One potential 
explanation is that the severe myocarditis in these animals masked the diabetes 
phenotype.  Indeed, MDA5-/- animals were seen to have increased viral titers in the 
pancreas as well as increased insulitis upon histological examination compared to WT 
mice, suggesting that in the absence of myocarditis, diabetes would have developed.  This 
could be directly tested using mice lacking MDA5 only in the β-cells.  More importantly, 
this study did not address the role of MDA5 in autoimmune diabetes.  The animals used 
in this work were on the C57Bl/6 background, which do not develop spontaneous 
autoimmunity.  To properly evaluate the role of MDA5 in autoimmune T1DM, it is 
necessary to have the mutation on the NOD background either by backcrossing or 
making the knockout in newly created embryonic stem cells derived from NOD.  These 
mice could then be tested for development of diabetes to determine how a lack of MDA5 
affects autoimmunity in these animals. 
 Data implicating TLR3 in autoimmune diabetes is less supportive than that of 
MDA5.  The primary association was seen using a model of diabetes in which a mouse 
expressing a transgene for LCMV-GP developed autoimmune diabetes only after the 
administration of pIC or virus(10).  The authors suggested based on these results that 
TLR3 was important for autoimmune diabetes, although this was never directly tested.  
However, the existence of MDA5 was not known at that time, and it is likely that the 
response to pIC was dependent on MDA5 and not TLR3 in these transgenic animals.  
Moreover, mice lacking TLR3, which were backcrossed to the NOD background 
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demonstrated no defect in the development of diabetes compared to WT NOD 
animals(11).  In humans, genome wide association studies have also provided no 
evidence that human TLR3 polymorphisms are implicated in T1DM.  Our data, however, 
reveals a role for TLR3 in virus-induced diabetes.  The pancreatic infiltrates seen in 
TLR3-/- animals closely resemble “pattern B” infiltrates seen by Dotta(12).  The question 
remains, how prevalent is the autoimmune versus virus-induced diabetes?  Clinically, 
there appears to be no difference between pattern A and pattern B patients, the difference 
was only detected histologically.  In addition, this study included only 6 patients, and it is 
unclear how representative this sample is to the population at large.  Recent work from 
nPOD (network of pancreatic organ donors) has begun to look at the pancreas of diabetic 
patients on a more global scale.  This project contains clinical as well as histological data, 
so it is possible that there will be clinical correlations to the histological findings that can 
be used to identify distinctions among T1DM patients.  If this is indeed possible, it would 
be interesting to know whether there are different genetic risk factors between the two 
populations. 
 
Myocarditis 
 Research into the mechanism of myocarditis has focused on whether the disease is 
mediated primarily by viral infection or autoimmunity.  Our results with EMCV infection 
indicate that a virus-dependent mechanism occurs in this system.  Increased viral titers in 
MDA5-/- animals, and to a lesser extent, TLR3-/- animals correlated with increased 
myocarditis as measured by histopathology and serum troponin levels.  We were unable 
to detect T cell infiltrates in the heart in these animals, however, we cannot rule out 
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immunopathology mediated by innate cells in this system.  It is known that the genetic 
background influences the response to EMCV infection in mouse models.  The mice we 
used in this study, strain C57Bl/6, develop acute myocarditis in response to EMCV, and 
it would be interesting to known the effect of MDA5 and TLR3 deficiency in mouse 
strains which develop chronic myocarditis consistent with autoimmune etiology.  It is 
possible that on those backgrounds MDA5 and TLR3 may contribute to autoimmunity A 
very recent human study has revealed that TLR3 polymorphisms are associated with viral 
myocarditis and dilated cardiomyopathy(13).  In this study susceptibility to myocarditis 
correlated with TLR3 alleles demonstrating reduced downstream signaling capacity in 
vitro.  This suggests that select cases of human myocarditis correlate with failure to 
control viral infection, similar to our findings in the mouse system, and may explain the 
benefit of IFNβ therapy seen in clinical trials. 
 
Gastroenteritis 
 In our study, we demonstrate that both MDA5 and TLR3 were necessary for 
complete control of MNV infection.  The absence of either sensor resulted in an increase 
in viral titers, while deficiency of both sensors had a more profound defect (data not 
shown).  It is unclear whether human MDA5 and TLR3 polymorphisms result in 
differential susceptibility to norovirus infection, but it is likely, based on the mouse data, 
that inactivating mutations may lead to more severe norovirus infection.  Recent findings 
have demonstrated the importance of both innate immune genes and environmental 
factors in the pathogenesis of inflammatory bowel disease.  Genes involved in autophagy 
as well as PRRs for bacterial ligands have been implicated in the disease process.  
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Moreover, the presence of intestinal viruses such as MNV has been suggested to be 
important for the full development of the disease phenotype in genetically susceptible 
animals(14).  In this model, genetic factors do not directly contribute to disease pathology 
in the absence of an environmental stimulus, but when both environmental and genetic 
factors are present, disease pathology results.  It is possible that by regulating the level of 
viral infection in the gastrointestinal tract, polymorphisms in MDA5 and TLR3 could 
contribute to development of inflammatory bowel disease by altering the environmental 
components of the disease.  This remains to be investigated. 
 
Implications for immune-targeted therapeutics 
 Stimulation with pIC activates both the MDA5 and TLR3 pathways, leading to 
cytokine production and immune activation.  We demonstrate that activation through the 
two sensors has unique properties, which may be useful for the targeting of therapeutics.  
Work by the Steinman group has shown that pIC is a very strong adjuvant that leads to 
robust activation of a T cell response in the context of a tumor vaccine(15).  However, 
work from our lab has shown that pIC stimulation of MDA5 and TLR3 has distinct 
effects on the T cell response.  While TLR3 is necessary for a robust primary response, 
MDA5 is critical for the memory T cell response(16).  These results suggest that 
targeting pIC to the correct hematopoietic or stromal compartment may help to ensure the 
desired T cell response in the context of vaccination.   
 Cell-specific targeting of pIC may also be useful in cancer therapy.  There has 
been much effort towards the development of cancer vaccines that would activate the 
immune response to attack tumor cells.  To date, this strategy has been largely 
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unsuccessful.  There is hope that the use of pIC will boost the effectiveness of this 
therapy.  PIC has several beneficial effects on the immune response to tumors.  It 
activates NK cells, which can kill transformed cells; it activates antigen presenting cells, 
priming the T cell response; and it activates T cells directly.  By targeting pIC treatment 
directly to specific immune cell types it may be possible to enhance the anti-tumor 
immune response.  In addition, pIC has a direct anti-tumor role in some cancers.  Studies 
of breast and liver cancers demonstrate that tumor cells that express TLR3 are susceptible 
to apoptosis upon pIC treatment(17, 18).  More recent evidence also implicates MDA5 in 
susceptibility to pIC.  Many melanomas upregulate MDA5 and are thus highly 
susceptible to apoptosis upon delivery of pIC intracellularly.  This effect was partially 
dependent on MDA5-mediated IFN production, but partially independent of IFN(19, 20), 
suggesting that MDA5 plays a direct role in apoptosis.  Further studies are necessary to 
determine whether MDA5 is upregulated in other types of cancers and if it can be 
exploited.  These exciting advances suggest that the ability of pIC to activate both anti-
tumor immunity and direct tumor cytotoxicity make it a potentially useful therapeutic 
agent. 
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Conclusions 
 In this work we have shown that the dsRNA sensors MDA5 and TLR3 play 
distinct roles in controlling viral infection.  These sensors have unique cellular and tissue 
expression profiles and stimulate production of distinct cytokine patterns when exposed 
to their ligands.  The ability of these sensors to recognize viral infection and initiate 
production of interferon and inflammatory cytokines, both of which may play a role in 
the development of autoimmunity, suggests that alteration of their activity could lead to 
human disease.  Indeed, polymorphisms in the genes encoding MDA5 and TLR3 have 
been associated with T1DM, myocarditis, and encephalitis, and we are beginning to 
understand the mechanisms by which these diseases develop.  In addition to 
understanding the underlying disease mechanisms caused by these genes, it may be 
possible to use our understanding of tissue distribution and receptor-specific signaling 
pathways to target these pathways for human therapeutics.  Knowledge of MDA5 and 
TLR3 function may lead to important advances in vaccines, autoimmunity, and cancer 
therapy.  We hope that this work will lead to further discoveries in these fields.  
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